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CHAPTER 1 
INTRODUCTION 
With the increasing success of irradiation and chemotherapy in 
prolonging the lives of patients with malignant diseases one started 
to realize that permanent damage to self-renewing cell populations 
may be induced. Damage to the gonadal cells causes infertility and 
often permanent sterility (17,21,36,37). Since a large proportion of 
patients undergoing treatment is young, this particular side-effect 
may create serious problems. Radiation therapy, for instance in the 
early stages of Hodgkin disease (16), is leading to prolongation of 
life in persons of child bearing age. However, gonadal dysfunction 
occurs (9,19,21,34,35) as an important iatrogenic side effect. In 
male patients this can result in permanent azoospermia or severe 
oligospermia (7,8,35). Even when the testes are shielded, internal 
radiation scatter is still a significant problem (35). This side 
effect of exposure to radiation is of increasing importance. Current 
research efforts are made (6,14) to decrease treatment related 
complications. A treatment which would reduce the magnitude of 
testicular damage after irradiation is highly desirable and could 
result in preservation of reproductive function. 
Many authors (18,20,22,23,24,25) have reported spermatogonia to 
be the most radiosensitive germ cells. It was possible to 
selectively destroy most of the spermatogonia! population by 
irradiation without damaging other cells. Depletion of 
spermatogonia resulted in disappearance of cells in their order of 
developmental sequence and eventually resulted in loss of sperm. 
However, as early as 1955, Oakberg (22,23) remarked on the 
heterogeneous sensitivity of spermatogonia in the mouse, noting that 
some survived doses as high as 15.0 Gray (Gy) with eventual return 
of fertility. This was confirmed in a number of subsequent studies 
(3,4,27,28,29,30,31,38). The type of spermatogonium which is 
radiation resistant, is the most important cell type in reference to 
fertility effects of radiation. The pivotal question concerning the 
identification and characterization of the radioresistant 
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spermatogonia was answered by studies (10,13,26) of irradiated 
testes. The radioresistant spermatogonia appeared to be the isolated 
stem cells found in normal testis. Shortly after testicular 
irradiation stem cell spermatogonia are almost the only 
spermatogonia present (5,12,13). They keep their capacity to 
replenish their own numbers and to differentiate and eventually 
contribute to restoration of the spermatogonia! population. All long 
term effects of testicular irradiation are primarily related to the 
response of these stem cell spermatogonia. 
It has also been observed (20,26) that depletion of the 
spermatogonia! population by irradiation provokes enhanced mitotic 
activity among surviving stem cells throughout the epithelium and a 
large number of these cells enter the S-phase of their cell cycle at 
times when they do not normally synthesize DNA (11). Erickson (4) 
observed in the rat stem cell that mitosis is extremely sensitive to 
low dose irradiation. It was suggested (2,28,31,32,38), that the 
sharp increase of stem cell radiosensitivity occuring shortly after 
irradiation, could be attributed to a change of surviving stem cells 
towards a much more radiosensitive phase of their cell cycle. The 
implications of such an effect would suggest a particular 
vulnerability of the stem cell at particular intervals, a 
vulnerability that could lead to lasting sterility through 
elimination of the stem cells themselves. Conflicting results have 
been reported concerning stem cell survival after fractionated 
irradiation. Withers et al. (38) and Lu et al. (15) showed enhanced 
stem cell survival when the dose was split into two equal fractions, 
whereas Oakberg (28) and Cattanach (1) reported no consistent 
changes. Some studies (31,32,33) showed split-dose irradiation 
indeed to decrease the number of surviving stem cells depending on 
the time interval between the two dose fractions. In this way the 
surviving spermatogonia! stem cells play a critical and fundamental 
role in assuring the perpetuation of the germ line. The triggering 
factor, however, provoking altered stem cell kinetics in response to 
irradiation remains unknown. Even the mechanisms involved in 
inducing some stem spermatogonia to enter the proliferating 
compartment under normal physiological circumstances still has to be 
solved. 
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It seems reasonable to suppose that the germinal epithelium is 
stimulated to compensate for a failure in maintaining normal 
spermatogenesis. Surviving stem cells might be stimulated after 
irradiation to divide and thus be at increased risk for further 
damage. Because spermatogenesis is a highly regulated, hormonally 
controlled proliferative system, our hypothesis is that inhibition 
of spermatogenesis by hormones may reduce the stimulus of stem cells 
to move into the very radiosensitive phase. Inhibition of follicle 
stimulating hormone (FSH) and/or luteinizing hormone (LH) release or 
inhibition of their effects on the testicle could place the testis 
in a state comparable to that of prepuberty. This resting state 
could make the germinal epithelium more resistant to irradiation and 
could in this way protect the stem cell from depletion. To test this 
hypothesis a rat model was investigated where irradiation produced 
severe damage to spermatogonia and administration of various 
hormonal substances was used to achieve reversible inhibition of 
spermatogenesis. 
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REVIEW OF THE LITERATURE 
2.1 Spermatogenesis of the rat 
The seminiferous epithelium of adult, sexually mature rats is 
composed of differentiating germ cells intercalated between the 
supporting Sertoli cells. The mitotically active cells in the 
seminiferous epithelium are called spermatogonia. These cells are 
found exclusively on the basement membrane of the seminiferous 
tubules below the sertoli junctional complexes. After a series of 
divisions, spermatogonia form primary spermatocytes, which grow, 
leave the basement membrane and move towards the lumen. During this 
period of growth the nucleus of the primary spermatocyte undergoes a 
series of changes before the first meiotic division appears. After 
full development the primary spermatocyte divides into two smaller 
secondary spermatocytes, (second meiotic division) by which 
spermatids containing a haploid number of chromosomes are produced. 
Coincident with the onset of meiosis, the early primary 
spermatocytes transverse the occluding sertoli junctions. As 
differentiation proceeds, the spermatocytes and early spermatids are 
gradually moved towards the lumen of the seminiferous tubule. 
Spermatids become closely connected with the Sertoli cell and 
undergo an extraordinarily complex series of changes, leading 
without further divisions to the production of the highly 
differentiated germ cell, the spermatozoon (23). 
The spermatogonia, spermatocytes and spermatids at various steps 
of development do not occur at random but form well-defined cellular 
associations. Analysis of the composition of these various cell 
associations reveals that they appear in a given area of a tubule 
and follow each other in a given and fixed sequence. Since such a 
sequence must repeat itself, the seminiferous epithelium as a whole 
evolves in a cyclic manner and a complete series of typical cell 
associations constitutes "a cycle of spermatogenesis". The typical 
cell associations are referred to as stages of the cycle. Such 
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stages represent artificial subdivisions through a continous process 
and vary depending on the criteria to characterize or identify them 
(9). 
With the advent of radioactive tracers and the development of 
autoradiography it became possible to determine the duration of the 
spermatogenic "cycle". Tritiated thymidine, which is selectively 
incorporated in the nucleus of cells has been used extensively to 
time the cycle. Huckins (38) determined the duration of the cycle in 
the wistar rat to be 13.3 days, whereas Hilscher (36) estimated a 
duration of 13.0 days. This cycle length seems to be constant. The 
duration of the whole process of spermatogenesis was estimated to be 
53.2 and 53.0 days respectively. In 1968 Clermont and Bustos-Obregon 
(10) introduced an alternative technique for studying spermatogonia 
using whole mounts of seminiferous tubules instead of sections. This 
led to a more detailed insight into the different types of 
spermatogonia. Their study presented evidence for the existence of 
two main classes of type A spermatogonia stem cells. They observed 
an "isolated" germ cell in the rat testis that did not appear to 
participate regularly in the spermatogenic cycle. Since mitoses of 
these cells were seen infrequently, the authors proposed that these 
spermatogonia represented reserve stem cells, which did not normally 
participate in the spermatogonia! stem cell renewal. This cell type 
was named consequently as "Ao" stem cell (Fig. 2.1). The other 
cells, which participated in the spermatogenesis were referred to as 
renewing stem cells. 
During the past decade most of the research has been focussed on 
the spermatogonia. Huckins (39) and Oakberg (67) further scrutinized 
the "Ao" spermatogonium by means of isotope and morphological 
techniques and came to the conclusion that spermatogonia! stem cells 
came from a continously cycling population and not from a 
non-cycling one as required by the "Ao" concept. The stem cell was 
probably not a reserve stem cell. The stem cell should therefore be 
designated as "As" (s for stem). It was suggested that these "As" 
cells occur isolated rather than in groups and are distributed 
randomly throughout the length of the seminiferous tubule. Huckins 
(39) proposed a new hypothesis for a stem cell renewal model in the 
rat on the basis of quantitative réévaluation of whole mounts of 
8 
Model Clermont Model Huckins Model Enckson 
* 0 
1 
* л 
1 
* 1 
1 
* 1 
* A4> 
* INT 
t 
В 
* * * , H a * A s - . A B ( l c ) 
Apr 
»*., 
i 
\ * 1 
» A, 
t A, 
t 
A, 
« IMT 
« 
в 
Spermatocylee 
Spermatids 
r A l , i 
Apr 
«'.J 
І 
t 
A, 
« Aa 
i A, 
i 
A. 
« INT 
« 
В 
FIG. (2.1) Diagrammatic representation of spermatogonia! stem cell 
renewal for the rat as proposed by Clermont and Bustos-Obregon 
(10), Huckins (40) and Erickson (22). 
seminiferous tubules. In this model (Fig. 2.1), the daughter cells 
of the "As" cells retain their proximity and form pairs of 
spermatogonia (Apr) or they can divide to form more single "As" 
cells (self-renewal). Successive synchronous divisions of the pair 
lead to the formation of a chain of 4, 8 or 16 A aligned 
spermatogonia (Aal), which retain the "As" nuclear morphology. 
However, these "Aal" cells stop dividing and transform into Al 
spermatogonia. Pair formation is considered to be the initial step 
in an irreversible developmental sequence. The chain of "Aal" cells 
appear to have contiguous cytoplasm under the light microscope (44) 
and with the electron microscope intercellular bridges were observed 
(18) between spermatogonia. These bridges are an important factor in 
maintaining the synchrony in spermatogonia! proliferation. All 
members of a given chain are morphologically identical and are in 
the same phase of their mitotic cycle. 
Intriguingly more and more evidence arose that this stem cell 
Stem cell 
Spermatoflonia 
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compartment "As" is probably composed of more classes (34) . 
Autoradiographical (40,67), and radiobiological studies 
(6,14,50,68,77,97) show indications for heterogenic behaviour of 
spermatogonia! "As" stem cells. Wether these subpopulations 
represent two different cell types (6,50) or different stages in the 
cell cycle of a single cell (14,68,77,97) still remains to be 
answered. 
2.2 Regulation of spermatogenesis 
Germinal epithelial cells proliferate continously throughout the 
adult life of a male requiring a constant supply of germ cell 
precursors. Large groups of germ cells evolve synchronously 
throughout the spermatogenic process. Spermatogonia must arise 
periodically to replace those that differentiate into spermatocytes, 
which in turn yield spermatids and spermatozoa. The mechanisms 
responsible for regulating this process have been the topic of many 
investigations, and, although a number of theories have been 
proposed, including those that Sertoli cells are transformed into 
germinal cells or that cells of the wall of the seminiferous 
epithelium may transform into spermatogonia, evidence points towards 
the principle of a self-renewing germinal stem cell. 
2.2.1 Stem cell renewal 
The precise manner in which stem cells renew remains poorly 
understood, although there are some theories (Fig. 2.1): 
1. Clermont and Bustos-Obregon (10) divide the spermatogonia of 
the rat into two groups. The first contributes the actively 
renewing population and comprises the cell types A1-A4 
spermatogonia. The second group consists of a cell type 
designated as "Ao", which are non-dividing single cells. These 
cells are considered to be reserve stem cells that become 
active only if the more mature spermatogonia! types are 
depleted by a noxious agent such as radiation. 
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2. In the stem cell renewal model of Huckins (40) the stem cell 
"As" has two potentials: It divides to form more single "As" 
spermatogonia; or division may result in the formation of a 
pair of cells (Apr). Pair formation is considered to be the 
initial step in an irreversible sequence. 
3. According to Erickson (22), the stem cell (As) could possibly 
be produced by breakage of intercellular bridges between A 
paired (Ap) and A aligned (Aal) cells. Thus "Ap" and "Aal" 
cells might split into two "As" spermatogonia. 
Evidence from experimental studies (21,45,49,67,69,76,97) in which 
the spermatogonia! population was depleted, clearly fits best with 
the stem cell renewal model of Huckins (40). 
2.2.2 Regulation of spermatogonia! proliferation 
The complexitiy of producing vast numbers of germ cells in a 
precise manner and coordinative pattern requires regulatory 
mechanisms. The mechanisms which regulate this process or the 
factors, which are responsible for this regulation still remain 
unclarified. Hormones certainly are involved in the regulation of 
spermatogonia! proliferation (see chapter 2.2.3). 
Because spermatogenesis is a very rigid time scaled process it 
was suggested that some intratesticular mechanisms must exist to 
regulate this proliferation. The depletion of differentiating germ 
cells from the testis following X-irradiation leads to an apparent 
compensatory increase in the proliferation of the spermatogonia! 
stem cells (17,41,43). Huckins and Oakberg (45) noticed that 
enhanced activity of stem cells coincided with the period of the 
epithelial cycle in which many differentiating spermatogonia 
degenerate, suggesting a local feedback mechanism. It was also 
observed that the cycle of the seminiferous epithelium proceeded 
more rapidly in juvenile than in adult animals (38). Another 
phenomenon which should be mentioned here is the observation of van 
Keulen and de Rooij (48,49) that after severe cell loss the 
production of spermatogonia type A paired is inhibited for a certain 
11 
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time. These observations suggest that the proliferation of 
spermatogonia is modulated by some intragonadal factors. 
Most locally acting factors in a cell renewing system generally 
are small peptides. A survey of the current literature (82) shows a 
substantial list of potential factors, such as oxytocin, 
vasopressin, endorphins, thyreotropin releasing hormone, epidermal 
growth factor and somatodins, which may be involved in local 
regulation of testicular function. It was also suggested that 
spermatogonia! proliferation is subject to feedback regulation via a 
chalone-like substance. Several authors (12,46,92) found 
proliferation of spermatogonia in the rat to be inhibited by 
injection of a testicular extract. As yet this "chalone" has not 
been isolated and it is still unknown which cell is responsible for 
its production. In which respect Sertoli cells influence 
spermatogonia! proliferation, directly or indirectly, still remains 
to be clarified. Feig et al. (24) claimed to have found a mitogenic 
polypeptide. This mitogenic protein, the seminiferous growth factor, 
is presumed to play a fundamental role in testicular physiology (2). 
Recently it was proposed by Sharpe (82) that an LH-RH like peptide 
is produced by the Sertoli cells within the testis, acting 
specifically in the Leydig cells interacting with LH and hence 
modulating the production of testosterone. As yet it is not certain 
how local factors play a role in the regulation of spermatogonia! 
proliferation. 
2.2.3 Hormonal control of spermatogenesis 
It has been clearly established in man, as in other mammalian 
species, that normal spermatogenesis requires the stimulatory action 
of pituitary gonadotropins (FSH and LH). The classical study of 
Smith (85) in 1930 unequivocally demonstrated pituitary control of 
gonadal functions in the rat and thus established firmly the 
importance of gonadotropins in testicular physiology. Clermont and 
Morgenthaler (13) showed in a quantitative morphological study in 
rats an extensive degeneration of germinal cells with a decreased 
number of spermatogonia and early spermatocytes following surgical 
removal of the pituitary. Also the numbers of pachytene 
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spermatocytes and spermatids drastically decreased, specifically at 
stage VII of the cycle of the seminiferous epithelium. Soon after 
partial purification of gonadotropins, the concept was proposed that 
LH acted on the Leydig cells in the interstitium, stimulating 
testosterone production, whereas FSH controlled spermatogenesis 
(27,28). It was demonstrated (15) that LH binds specifically to 
Leydig cells, where it stimulates cyclic AMP accumulation and the 
conversion of cholesterol to pregnenolone at the mitochondrial 
level, leading to increased formation of testosterone. The roles of 
FSH and testosterone in the regulation of spermatogenesis have been 
the subject of controversy for many years. The observations, that 
exogenous androgens can also maintain spermatogenesis in 
hypohysectomized rats (61,95) confused the originally proposed neat 
design (27) of FSH control in the regulation of spermatogenesis. 
Many studies were set up to learn which part of germ cell 
development was influenced by the different hormones. In 1971, it 
was generally assumed that the various stages of spermatogenesis 
require specific but not necessarily the same hormones (87). FSH was 
thought to act on the completion of spermiogenesis and formation of 
spermatozoa, whereas completion of the meiotic division was 
described (88) to be a specific testosterone-dependent step in 
spermatogenesis (87,88). In the last ten years more and more 
evidence, however, suggests that the effects of FSH and testosterone 
are mediated by the Sertoli cells (30,31). It seems that Sertoli 
cells are the primary site of FSH action in the testis and that 
production of a specific androgen binding protein (ABP) by the 
Sertoli cells is stimulated by FSH (89). Direct binding of FSH to 
tubules containing only Sertoli cells is in agreement with this 
(32). Binding of FSH to Sertoli cells is followed by cyclic-AMP 
accumulation, protein kinase activation, RNA synthesis and ABP 
production (55). Rat Sertoli cells in culture secrete a Sertoli cell 
factor (SCF) which selectively suppresses FSH production by 
pituitary cells in vitro (91). Such a substance was first postulated 
in 1932 by McCullagh (54). This substance was further investigated 
under the name inhibin (33,52,90). More data must be derived to 
explain the exact role of an inhibin substance in the feedback 
regulation exerted in the pituitary gland. Secretion of ABP by 
13 
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Sertoli cells was shown to be correlated with the state of 
spermatogenesis under different hormonal conditions (74). There is 
evidence that the Sertoli cells are also target cells for androgens 
(29,60,94). Studies using immature or adult hypophysectomized rats, 
revealed that testosterone can stimulate the activity of ABP as can 
FSH (20,80,93,96). At the moment it is generally assumed that the 
effects of FSH and testosterone on spermatogenesis are mediated by 
Sertoli cells. Still the mechanism by which Sertoli cells act upon 
germ cells and especially on spermatogonia! proliferation remains to 
be elucidated. 
A direct influence of FSH and testosterone on spermatogonia! 
proliferation has not been well established to date, although FSH 
binding to spermatogonia was suggested by Orth and Christensen (70). 
Chowdhury (8) showed that spermatogonia may be partially dependent 
in their function on testosterone-propionate and/or gonadotropins. 
FSH seems to be particularly important for initiation of 
spermatogenesis during the development of the testis in immature 
rats (51) and also during the development as well as for restoration 
of spermatogenesis after gonadal damage (19,87). However, the 
effects of FSH and testosterone on spermatogonia are peculiar in 
that they can not be demonstrated in intact adult rats. Such data 
raised the assumption that FSH and/or testosterone may be important 
only during the critical period of initiation of spermatogenesis 
(25). It is possible that FSH and/or testosterone in this way are 
essential in stimulating stem cells after severe loss to produce new 
spermatogonia. This role of FSH would be compatible with the 
apparent loss of spermatogonia in prepubertal rats following 
treatment with an FSH antibody (7). 
14 
2.3 Testicular irradiation 
Soon after the discovery of X-rays it was realized that these 
penetrating radiations induced striking alterations in living 
tissue. In 1903 Albers-Schönberg (1) first described radiation 
damage to the testis. In 1905 Bergonie and Tribondeau (3) noticed 
the skin of the scrotum to be unaffected despite the fact that the 
animal lost its fertility. Régaud and Blanc (75) recognized among 
the germ cells of the testis, spermatogonia to be extremely 
sensitive to X-rays. On the basis of early experimental studies of 
radiation effect on the testes, Bergonie and Tribondeau (4) 
postulated that the radiosensitivity of cells is determined by their 
degree of differentiation, their mitotic rate and their mitotic 
future. Experimental evidence later on (35,53,81) confirmed that 
spermatogonia with a high mitotic rate were much more sensitive than 
spermatocytes or spermatids. This high radiosensitivity of 
spermatogonia, however, could also be related to the presence of 
intercellular bridges (42), which play an important role in the 
synchrony of an entire chain of proliferating spermatogonia: An 
entire chain dies or survives. Depletion of spermatogonia resulted 
in disappearance of cells in their order of developmental sequence 
and eventually resulted in loss of sperm. However, a few 
spermatogonia survived and could repopulate the germinal epithelium. 
Thus both the initial depletion and the subsequent regeneration of 
the spermatogenic elements depend upon the response of the 
spermatogonia. Later studies on the effect of radiation on mammalian 
seminiferous epithelium focussed in particular on the spermatogonia! 
population. Testicular irradiation investigations, however, were 
hampered by either incomplete or inaccurate knowledge of the 
kinetics of spermatogenesis. 
A new impulse in this research came after the Second World War 
when a better understanding of the effects of irradiation of the 
testis became possible by an increase in the knowledge of the 
dynamics and timing of spermatogenesis and especially of the process 
of spermatogonia! cell renewal. Studies on mouse (58,59,62,63,64,65) 
and rat (5,14,16,36,47,71,83) testes clearly demonstrated that the 
spermatogonia (intermediate and type B) are particularly sensitive 
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to irradiation and that type A spermatogonia appear to be of a 
heterogeneous population. Among type A spermatogonia some are very 
resistant to irradiation and these surviving cells contribute to 
restoration of the spermatogonia! proliferation. 
Questions arose about the identification and characterization of 
the radioresistant spermatogonia. Utilizing a tubule whole-mount 
method Clermont and Bustus-Obregon (10) observed in 1968 an isolated 
germ cell type in rat testis that was not regularly present in the 
spermatogenic cycle; this cell was called type "Ao" spermatogonia 
(see chapter 2.1). Dym and Clermont (17) concluded that these stem 
cells "Ao" were comparitively more radioresistant than spermatogonia 
type Al. These radioresistant cells were considered to belong to a 
dormant reserve stem cell population, which became mitotically 
active only in response to germ cell depletion. Another phenomenon 
described by them was that the radioresistant spermatogonia entered 
into spermatogenesis at fixed and predetermined times. In other 
words, the proliferative activity of radioresistant spermatogonia 
appears to be a rigidly regulated process. Later on, experimental 
evidence accumulated showing that stem cells labeled with tritiated 
thymidine prior to irradiation survived the radiation insult (67), 
and hence must be in active cell cycle. Huckins (39), Oakberg (67) 
and Rooij et al. (76) postulated that the isolated spermatogonia 
are functional stem cells. Moreover it became clear from studies 
(21,44,45,69) of irradiated testis and observations on whole mounted 
seminiferous tubules that the radiosurvivers are the cycling type A 
stem cells found in normal testes. 
The stem cell response during irradiation is of great importance 
in terms of long term radiation effects. Proliferating systems are 
normally compartmentalized and the cell cycle may be divided into 
four phases (37): G1 (the presynthetic period), S (the DNA 
synthetic period), G2 (the post synthetic period) and M (the period 
of mitosis). Radiation profoundly disturbs the kinetics of cellular 
proliferation and the response of cell renewal systems in general is 
to establish a new steady state of cell production. The 
proliferative compartment may expand after cell loss by compensatory 
cell proliferation, either by increasing the proliferation rate of 
dividing cells (shortening of cell cycle) or by bringing into 
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proliferation potentially proliferative non-dividing cells. Huckins 
(39) and Oakberg (67) noticed that depletion of the spermatogonia! 
population by irradiation provoked enhanced mitotic activity among 
the surviving "As" stem cells. An increased frequency of cells 
labeled by tritiated thymidine in the irradiated testis was observed 
(66). A large number of "As" survivors enter the S-phase of the 
cell cycle at times when they do not normally synthesize DNA (39). 
Which factor triggers these cells to enter the S-phase is unknown. 
Erickson (21,22) described the high radiosensitivity of stem cell 
mitosis after a second dose of irradiation. Stem cells would be 
more vulnerable after irradiation because they move into mitosis. 
This suggested a particular vulnerability of the stem cell at 
particular intervals. It was shown in the mouse (78) that after a 
single dose of irradiation stem cells immediately (after 16 hours) 
became vulnerable. A second dose would destroy these cells and 
could lead to elimination of the stem cells themselves. 
This elimination of stem cells is controversial: Withers et al 
(97) and Lu et al. (50) showed enhanced stem cell survival when the 
dose was split into two equal fractions. Ruiter-Bootsma et al. 
(78,79) and Sheridan (84) demonstrated lower stem cell survival upon 
fractionation, whereas Oakberg (68) and Cattanach (6) reported no 
consistent changes in stem cell survival after fractionation. This 
controversy may be explained by the different methods (50) used in 
evaluating stem cell survival. Spermatogonia! stem cell survival 
after irradiation injury was studied in mice by histological counts 
of surviving stem cells (68), counts of repopulated tubular cross 
sections (78,79,97), sperm head counts (50), LDH-X enzyme activity 
(50) or by the duration of the sterile period (6,50,84). 
Another point of disagreement is the existence of radiosensitive 
and radioresistant subpopulations of stem cells. Cattanach (6) and 
Lu et al. (50) found evidence for that existence, while Oakberg 
(68), Ruiter-Bootsma et al. (78) and Withers et al. (97) did not. 
Autoradiographic studies (11,21,36) showed that in normal rats, a 
few of the tritium labeled "As" cells persisted for many days, up to 
13 days or more in the seminiferous epithelium. These cells were 
designated by Huckins (40,41) as long cycling "As" spermatogonia 
(Ale). Huckins provided evidence for the existence of two 
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kinetically identifiable populations of "As" (Fig. 2.1) cells: One 
with a long cycle (Ale) and one with a short cycle (Asc). In case of 
testicular damage the "Ale" stem cell population could be 
immediately triggered in short cycling cells. Other authors have 
reported similar findings (11,21,36,66) but Huckins (41) showed that 
the radioresistant stem cell has a labelling pattern which is 
identical to that of the long cycling "As" spermatogonia in normal 
testis. Huckins suggested that these long cycle stem cells probably 
are arrested in the presynthetic period of the cell cycle 
(Gj-phase), like somatic cells. This could explain the high 
radioresistance of these cells. This possibility was also suggested 
by Smith and Martin (86). They hypothesized that there is only one 
stem cell compartment in which the cells cycle at random. 
Furthermore the heterogeneity in autoradiographic (63) or 
radiobiologic (50,77,97) behaviour of stem cells can be explained by 
the different characteristics of the phases of their cell cycle. In 
this model the stem cells do not constitute two separate 
compartments but belong to the same population. 
2.4 Protection of stem cells during irradiation 
A variety of chemical substances have been demonstrated to 
protect stem cells to some extent from radiation injury (73). A 
protecting compound against ionizing irradiation was first described 
by Patt et al. (72) in 1949. A number of large synthesis programs 
were undertaken in an attempt to find highly effective compounds. 
They came up with a number of promising compounds, many of which 
were in the thiophosphate class (98). One of them 
S-2-(3-aminopropylamino) ethylphosporothioic acid (WR-2721) was 
shown (56,57) to be able to protect testicular stem cells in mice 
against irradiation. A synthetic analogue of gonadotropin 
releasing-hormone was described to ameliorate the gonadal toxicity 
of systemic chemotherapy (26). No literature, however, is available 
about the use of hormones in protecting testicular stem cells 
against irradiation. 
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OUTLINE OF THE STUDY 
Although the spermatogonia! stem cells appear to be very 
radioresistant cells (9,11,26,27,26,29,34,40), their state of 
radioresistance is not a permanent one (11,34,36). The implication 
of variations in radiosensitivity of stem cells, suggests particular 
vulnerability at particular intervals. A survey of the literature 
(Fig. 3.1) of the survival of testicular stem cells after 
fractionated irradiation, however, shows conflicting results. 
Withers et al. (40) and Lu et al. (21) showed enhanced stem cell 
survival when the dose was split into two equal fractions, whereas 
Stem cell survival upon fractionation 
Enhanced Lower No consistent changes 
» H R Withers et al 1974 
(repopulation index) 
• C C Lu et al 1ββΟ 
(sperm numbers) 
( I d h > activity! 
( s t e n l e period ) 
» A L de Ruiter et al 1977 
(repopulation index) 
> W Sheridan 1971 
(stenle period) 
• E F Oakberg 1978 
(number of Aal spermatogonia) 
• В M Catlanach 1974 
(sterile period) 
FIG. (3.1) Stem cell survival after split dose irradiation as found 
by different authors. 
Oakberg (27) and Cattanach (4) reported no consistent changes. 
It has been shown (34) that in the mouse a first dose of 
irradiation triggers the stem cells to pass into a very 
radiosensitive phase of their cell cycle after 16 hours. A second 
dose of irradiation, however, will destroy these sensitive stem 
cells (11), suggesting that depletion of stem cells will occur 
(34,36). The factor responsible for triggering these cells in the 
radiosensitive phase is still unknown. It is possible that the 
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change in radiosensitivity can be explained by the change in the 
phase of the cell cycle of the stem cells (14,26,34,40). Each phase 
of the cell cycle has a different sensitivity to irradiation (25). 
This phenomenon was also described by Sinclair and Morton (38). They 
found that, with the exception of mitosis, cells are most 
radiosensitive just towards the end of the Gj-phase. They then 
become progessively more resistant as they progress through the 
S-phase, but become more sensitive when they pass into the С
г
-phase 
before the next mitosis. The most radiosensitive point in the cycle 
is when cells are completing Gj and commencing S-phase. 
From a theoretical point of view, hormones could be considered to 
be able to reduce or to avoid radiation damage, arresting cell 
division in the radioresistant phase. This could protect stem cells 
from depletion, resulting in preservation of reproductive function. 
By inhibiting cell division, there may also be a greater opportunity 
for repair of radiation induced damage. While proof of this 
hypothesis is lacking, its validity can be tested by interrupting 
the pituitary-gonadal axis by hormones during testicular 
irradiation. 
To interrupt the pituitary-gonadal axis during or prior to 
irradiation procedures, two drugs with known hormonal inhibitory 
Si 
effects on spermatogenesis were tested. The first drug Danazol (a 
synthetic steroid derived from ethisterone) has been reported 
(2,7,8,10,30,31,32,37) to possess inhibiting effects on pituitary 
gonadotropins. The second drug, Zoladex (ICI 118,630), is a LHRH 
analogue. These analogues, are thought to have direct effects on the 
LHRH receptors in the pituitary gland, resulting in low serum 
concentrations of gonadotropins probably by down regulation 
(1,6,13,18,19,35) and desensitization. 
Since much is known about morphological aspects of 
spermatogenesis and the endocrine regulation of spermatogenesis in 
the rat (39), it was decided to use this species in the experiments 
performed. Because the "As" model of spermatogenesis of Huckins fits 
best with the present knowledge of spermatogonial proliferation and 
stem cell renewal in the rat (chapter 2.2.1), this model was applied 
throughout the thesis. Stem cell survival was measured by using the 
repopulation index (21,33,34,40) as an assay for stem cell survival. 
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A good correlation between this index and stem cell survival has 
been shown (33). Flow cytometric analyses were performed to measure 
the change in proliferation kinetics in the process of 
spermatogenesis. Flow cytometry has been developed over the last 
twenty years from an effort initially intended to count 
(3,5,12,15,24) and later to size particles (16,17,22) into a 
sophisticated analytical tool, which allows rapid quantitative 
evaluation of multiple properties of the individual cell. The 
haploid cells as measured by the flow cytometer correspond to 
spermatids. Sperm head counting by microscope was also used as an 
assay in evaluating stem cell survival (21,23). Meistrich et al. 
(23) showed the relationship between the rate of recovery of sperm 
production and stem cell survival. The level of sperm production 
after irradiation is also directly related to fertility. 
Irradiation was given in a single dose or split into fractions with 
or without hormonal treatment. To evaluate the effect on the 
different cell types, histological counting of the number of 
spermatogonia (type A, intermediate and type B) and the number of 
preleptotene spermatocytes was performed using the classification 
method as proposed by Leblond and Clermont (20). Serum gonadotropins 
and testosterone concentrations were measured to evaluate the 
hormonal suppression. 
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A COMPUTER MODEL OF SPERMATOGENESIS IN THE RAT 
CORRELATION WITH FLOW CYTOMETRIC DATA BASED ON 
AUTORADIOGRAPHIC CELL-CYCLE PROPERTIES 
M.J.P.G. van Kroonenburgh, H.J. van Gasteren, 
J.L. Beck and C.J. Herman 
(Published in Cell and Tissue Kinetics 19, 171-177, 1985) 
ABSTRACT. A computer model of rat spermatogenesis was created, 
based on autoradiographic studies of durations of the phases of the 
cell cycle (Gj, S, Gj and mitotic phases) of each germ-cell type. 
With this model it is possible to predict and to gain insight into 
the distinct changes of the DNA content occurring during the normal 
process of spermatogenesis. The relative proportions of haploid, 
diploid, S phase and tetraploid germ cells with increasing age of 
the rats were calculated. Calculated and actual experimental flow 
cytometry data were compared to test the accuracy of the model, and 
these show good agreement. The present work demonstrates that 
single-parameter DNA analysis of testicular cells is primarily a 
reflection of germ cells in the spermatocyte and spermatid stages of 
development, and of non-germ cells. The FCM single-parameter DNA 
analysis of testicular cells is relatively insensitive to changes in 
the stem cell and spermatogonia! stages of germ-cell development. 
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INTRODUCTION 
The currently most acceptable model of spermatogonia! stem cell 
renewal and differentiation to spermatids in rat testis is the model 
proposed by Huckins (13,15) and Huckins and Oakberg (16). In this 
model, the spermatogenic stem cells (As cells) renew themselves and 
also give rise to conjoined pairs of spermatogonia (Ap cells). 
Continued proliferation of the Ap spermatogonia gives rise to longer 
and longer chains of Α-aligned (Aal) cells. These Aal cells appear 
to transform into Al spermatogonia which will go on to proliferate 
and to differentiate into spermatocytes and spermatids. The duration 
of the different phases of the cell cycle of these spermatogenic 
cells has been well documented with the aid of autoradiography 
(10,11,14). 
In studying spermatogenesis, physiological, pharmacological, 
hormonal and radiobiological effects may affect one or more of the 
stages of germ-cell development from stem cell to spermatid. These 
effects are reflected in changes of the DNA distribution of 
testicular cells as measured by flow cytometry (FCM; 1,2,3,7,18). 
With this technique, it is possible to quantify the percentage of 
cells in the different phases of the spermatogenic cell cycle by 
using fluorescent dyes, which bind to cellular DNA (8,9,22). 
However, the stage(s) of germ cell responsible for the observed DNA 
changes can not be directly identified using FCM alone. Therefore a 
computer model of spermatogenesis, based on autoradiographic data in 
the literature and reflecting the phases of the cell cycle, has been 
developed to refine the recognition of germ-cell populations defined 
by FCM DNA measurements. 
MATERIALS AND METHODS 
Input data 
The populations of spermatogenic cells were analysed separately 
by compartments, each compartment consisting of cells in the same 
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phase of the cell cycle. These compartments and the time that each 
cell type spends in the compartment are we 11-documented in the 
literature (Fig. 4.1, based on: data from Hilscher et al. (10,11) 
and Huckins (14)). Those data were found using autoradiographic 
techniques and were originally expressed as the length (in hr) of 
the different phases of the cell cycle (Gj, S, G2 and M). In this 
study, these times have been considered to be independent of age and 
physical condition of the rat. It has been recognized histologically 
that spermatogenesis in normal rats includes several steps in which 
germ cells spontaneously degenerate, such that the seminiferous 
epithelium yields fewer spermatozoa than theoretically possible. 
There are three critical points in differentiation where extensive 
cell loss occurs (15). The first is during spermatogonia! 
A stemcell 
i 
A paired (1) 
A aligned (2) 
A aligned (4) 
A aligned (8) 
A aligned (16) 
Al spermatogonia 
A2 spermatogonia 
A3 spermatogonia 
A4 spermatogonia 
Intermediate 
i 
В spermatogonia 
spermatocyt 1 
spermatocyt 2 
G, 
»18 0 
13 0 
13 0 
13 0 
13 0 
13 0 
108 5 
7 5 
11 0 
10 0 
10 0 
9 0 
88 8 
S 
24 5 
25 0 
25 0 
25-0 
25 0 
25 0 
19 5 
20 5 
21 5 
23 0 
24 0 
25 5 
26 0 
G2 + M 
17 5 
16 5 
16 5 
16 5 
16 5 
16 5 
13 0 
11 0 (65%) 
10 0(38%) 
9 0 (9%) 
8 0 
7 5 
372 0(12%) 
6 0(15%) 
I 
spermatids 532 8(18%) 
FIG. (4.1) Duration (hr) of C-i, S, С
г
 and M phases of cell cycle 
in the maturation stages of spermatogenesis as found with 
autoradiographic techniques (10,11,11). Figures in parentheses 
indicate the percentage of degeneration in that stage of 
development, a normal process during spermatogenesis. 
development, involving primarily type A2 and A3 spermatogonia. 
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It has been shown that type A-spermatogonia degenerate during 
their mitotic peaks (4,15). The second critical step is during 
meiotic division of spermatocytes (15) and finally spermatids 
degenerate during the acrosome phase of spermiogenesis (20,21). The 
percentages of degeneration are given in Fig. 4.1 Besides the 
spermatogenic cells, non-germ cells such as Sertoli cells, Leydig 
cells, endothelial cells, etc. are present in the testis. The 
percentage of non-germ cells was variable in our model but generally 
adjusted to a stable value of 10% (6). 
Computer modelling 
Spermatogenesis can be represented as a family tree originating 
from a single stem cell born at t=0. Each branch of the tree 
represents a cell and is divided lengthwise into four segments which 
correspond to the four phases of the cell cycle. Every t hr a fixed 
number of stem cells begins spermatogenesis and develops according 
to Fig. 4.1 as a growing number of cells as time continues. The 
numbers of cells in each compartment can be computed and summed. The 
time axis is divided into discrete intervals (At). In the present 
study, At was chosen as 5 hr. Any arbitrary At can be chosen for 
modelling purposes, if it is short in relation to the times given in 
Fig. 4.1. The number of germ cells in the various stages of 
development and in the different phases of the cell cycle as a 
function of time, is obtained by summing the contribution of each 
individual stem cell, which basically gives an error function-shaped 
curve. Cells which degenerate (according to the percentages in Fig. 
4.1) are eliminated in the model. The development of the germ cell 
population has been modelled using the above algorithm as a function 
of age of the rat. The model is written in FORTRAN for a PDP 11/34 
computer operating under RT 11 (Digital Equipment Corp., Maynard, 
Mass., U.S.A.). 
Output data 
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The amount of DNA per cell can be expressed as the с value, 
representing the amount of DNA in a gamete. The Gj-phase cells and 
Gj+M-phase cells contain a 2c and 4c amount of DNA, respectively. 
Because cells in the Gz and M phases of the cell cycle have the same 
DNA content, they cannot be distinguished by single-parameter FCM 
analysis. Thus, for analysis in the present study, they are combined 
into a single phase (G2+M) with a 4c DNA content. Haploid cells 
(spermatids) have a le DNA content. By summing the total numbers of 
cells in each germ-cell development stage in each phase of the cell 
cycle, the relative proportions of the total germ-cell population in 
each phase of the DNA histogram can be computed. These data can be 
directly compared with real DNA data to verify the model. 
RESULTS 
The calculated DNA content frequency distributions in percentages 
of haploid (1c), diploid (2c), S-phase and tetraploid (4c) cells as 
a function of the age of the rat are presented in Fig. 4.2 The time 
axis of this figure is calibrated according to the results of 
Clausen et al. (2; see also Fig. 4.3). Examination of these figures 
shows that the model predicts a number of important features of 
germ-cell development. For example, after day 22, a rapid increase 
in haploid cells occurs, reaching a level of 70.1% of total 
testicular cells beyond day 52 (Fig. 4.2). The increase in 
tetraploid cells precedes the completion of meiosis, which in the 
model occurs on day 20 (Fig. 4.2). The tetraploid cells reach a 
maximum percentage of 52.0«. Alterations in the proportion of 
diploid cells and cells in the S-phase from rats of different ages 
are presented in Fig. 4.2. 
At the time of birth, a peak of cells in the S-phase is observed. 
The relative contribution of cells in the various stages of 
maturation to a total DNA histogram is summarized in Fig. 4.4 The 
calculated percentages of cells with 1c, 2c, S and 4c DNA content 
correlate well with observed FCM data from mature rats which have 
not been treated with hormones, drugs, etc. (data not shown). For 
comparison, data from FCM analysis of rat testis at different ages 
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FIG. (4.2) Percentages of haploid ( σ ) , diploid (b), S-phase (с) and 
tetraploid (d) cells in the germ-cell population of rat testis as a 
function of animal age. Birth=0 ( t ) . Data based on the computer 
simulation described in the text. 
are presented in Fig. 4.3 (data from Clausen et a l . , 2 ) . Comparison 
of Figs . 4.2 and Fig. 4.3 shows t h a t the model p r e d i c t s r e l a t i v e l y 
accurate ly the d i s t r i b u t i o n of c e l l s found experimental ly. 
DISCUSSION 
The computer model of r a t spermatogenesis presented in the 
present paper involves several s i m p l i f i c a t i o n s . F i r s t l y , the 
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relative amount of non-germ cells is adjusted to 10% of the total 
population obtained in a suspension of testicular cells. Secondly, 
the data on duration of the phases of the cell cycle presented in 
Fig. 4.1 are considered to be independent of the age of the rat. 
Thirdly, our model considers spermatogenesis to proceed in a 
population of cells whose proliferative rate is independent of any 
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FIG. (4.3) Percentages of haploid (σ), diploid (Ь), S-phase (с) and 
tetraploid (d) cells in the germ-cell population of rat testis as 
function of animal age. Birth =0 (t). Data based on F CM studies 
from Clausen et al. (2). 
homoeostatic mechanism. 
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Concerning this last point, labelling studies suggest that the 
duration of spermatogenesis from beginning of spermatogonia! 
differentiation to spermatozoal release is constant for each species 
(5). However, there is evidence that the process proceeds more 
rapidly in juvenile animals (12). Despite the limitations of the 
model, predicted values of cell-cycle distribution in testicular 
cell suspensions fit very well with experimentally found values by 
Clausen et al. (2). Comparison of FCM data from Clausen et al. (2) 
with our calculated data generally shows a good overall agreement. 
A discrepancy between experimental and calculated data is noticed in 
the tetraploid curves however (compare Fig. 4.2 and 4.3). The 
percentage of 4c cells at their peak, approximately 25 days after 
birth, is significantly different. According to our model, a transit 
time of the primary spermatocytes of 172 hours instead of 372 hours 
in the G2+M phase (Fig. 4.1) would give a much better correlation 
between the predicted and observed tetraploid cell curves. 
With the computer model it is also possible to predict DNA 
distribution changes after irradiation. Irradiation can selectively 
kill spermatogonia (17,19) leaving the stem cell intact. So 
depletion of spermatogonia will result in disappearance of 
spermatogenic cells at a specific stage of the maturation sequence 
and eventually in loss of sperm at a predictable time following 
irradiation. The surviving stem cells must eventually repopulate 
the germinal epithelium in sequence, according to Fig. 4.1 So 
fluctuations in the DNA distributions can be expected after 
irradiation (7) similar to the dotted lines shown in Fig. 4.2 
The most important conclusion from the present study can be drawn 
from an examination of Fig. 4.4. Fig. 4.4 shows that the 4c 
population as measured by FCM consists mainly (98%) of primary 
spermatocytes, due to their extended stay in G2+M phase (372 hr. see 
Fig. 4.1). The S-phase cells demonstrated by FCM are nearly equally 
divided between spermatogonia (43%) and preleptotene spermatocytes 
(57%). Spermatogonia are present in the 2c and 4c region in a 
relatively low percentage (0.2%). It is clear that routine 
single-parameter DNA analysis of testis cells is primarily a 
reflection of germ cells in spermatocyte and spermatid stages of 
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FIG. (4.4) Theoretical DNA content (c value) distribution as 
percentages of the whole population of germ cells as predicted by 
the simulation model, in the adult (> 52 days old) rat. Total 
percentages would be observed as a single-parameter DNA 
histogram. 
development and of non-germ, primarily 2c cells. The only 
single-parameter DNA measurement which may be sensitive enough to 
reflect small changes in the stem-cell and spermatogonia! 
compartments is the S-phase, where cells in the early stages of 
spermatogenesis are represented approximately equally with 
spermatocytes. Thus, an improved technique to examine the 
individual germ-cell developmental stages separately is highly 
desirable. This will be the subject of a subsequent report. 
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CHAPTER 5 
DNA ANALYSIS AND SORTING OF RAT TESTIS CELLS USING 
TWO-PARAMETER FLOW CYTOMETRY 
M.J.P.G. v. Kroonenburgh, J.L. Beck, J.W. Scholtz, 
U. Hacker-Klom and C.J. Herman 
(Published in Cytometry 6, 321-326, 1985) 
ABSTRACT. By use of two-parameter flow cytometry of rat testis 
cell suspensions stained with mithramycin for DNA (the peak 
amplitude of the fluorescence signal versus total fluorescence 
intensity integrated over time), eight cell compartments could be 
distinguished without pre-enrichment of the samples. Cells in these 
compartments were identified by sorting and subsequent microscopic 
examination. 
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INTRODUCTION 
Flow cytometric (FCM) analysis of human (13,17) and animal 
(2,3,4,7,8,11,15) testicular cells has primarily been done using the 
single parameter of total DNA stainability. Using this analysis, 
five distinct populations of cells can be identified. Two 
populations with a DNA index (DI) of approximately 0.5 (1c) 
represent round and elongated spermatids. At a DNA index of 1.0 
(2c), cells with a diploid DNA content are seen. These cells include 
spermatogonia, preleptotene spermatocytes and non-germ cells such as 
Sertoli and Leydig cells, fibroblasts, endothelial cells, and 
macrophages. Cells with S and С
г
+М levels of DNA are primary 
spermatocytes and spermatogonia (12). Meistrich and associates (12) 
reported distinguishing seven subpopulations of testicular cells 
that were identified by FCM and cell sorting. Because of the highly 
complex effects of both physiological and pharmacological stimuli on 
the subpopulations of germ cells, a more detailed analysis of these 
subpopulations would be useful in FCM measurement of changes in 
testicular function. A possible solution to this problem is offered 
by the fact that the chromatin structure of the various germ cells 
as well as the size and shape of their nuclei vary widely in the 
different stages of maturation from spermatogonia to elongated 
spermatids (1). These differences can be measured using simple DNA 
staining if the peak and the area of the DNA fluorescence signal are 
analyzed as separate parameters in a two-parameter FCM system. 
The aim of the present study is to identify the different 
populations observed by two-parameter FCM analysis of testis and 
thus evaluate whether this type of analysis would be more useful in 
giving detailed information on the various phases of the complex 
process of spermatogenesis in comparison with the single parameter 
usually used. 
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MATERIALS AND METHODS 
All experiments were performed with 3-mo-old male outbred Wistar 
rats (Cpb:WU) each weighing approximately 300 gm. 
Cell dispersal 
The testis was dissected free from fat and connective tissue. 
After decapsulation, the tissue was finely minced with scissors in 
15 ml phosphate buffer (pH=7.4;P04'- 23.8 mg/ml) and sieved through 
a 50-ym mesh filter. The mincing and preparations were done at room 
temperature. This cell suspension was passed through a 25-gauge, 
1-inch needle, centrifuged (370xg) for 10 min, and resuspended in 10 
ml phosphate buffer by vortexing. Debris was removed by filtration 
through a nylon filter (pore size: 50 μπι). The suspension was again 
centrifuged (370xg) for 10 min and the supernatant discarded. All 
aliquots were fixed in 50л ethanol (-20°C) and stored at 4I1C until 
analysis. 
Flow cytometry 
Staining was carried out in the dark at room temperature for 30 
min, as previously described (10,14). Briefly, 1 ml of cell 
suspension (about 3x10е cells ) was centrifuged 10 min (360xg) and 
the ethanol discarded. The cell pellet was resuspended in 1 ml 
staining solution consisting of 0.1 mg Mithramycin (MM: Serva Fein 
Biochemica, Heidelberg, W. Germany) per milliliter of 15mM MGC12 in 
0.85% NaCl. Flow cytometric analysis was performed on an Ortho 
System 50-H (Ortho Instruments; Westwood, MA) using the 457-nm line 
of the argon ion laser (Spectra Physics, Mountain View, CA) at 200 
mW power. A two parameter analysis was performed in a 64x64 data 
field, using the peak height of the fluorescence signal and the 
total intensity of the signal integrated over time. In some 
experiments, especially when studying the G2+M (DNA index=2.0) 
region, the right angle light scatter was also used as a parameter. 
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All data collected were stored in list mode. A right angular 
electronic window was placed around defined regions of interest and 
cells were sorted onto standard 3xl-inch microscope slides, stained 
with haematoxylin and examined microscopically for identification of 
subpopulations in the sorted FCM regions (see below). Sorts and 
microscopic examination were done on both peak-area and scatter-area 
analysis to show the relationship between the two types of analysis 
(Fig. 5.2). 
RESULTS 
FCM analysis of DNA stainability of rat testicular cells is 
shown in Fig. 5.1. This is a one-parameter distribution based on 
total fluorescence per cell integrated over time (area of the 
signal). If the peak height of the DNA fluorescence signal of each 
cell is used as a second parameter, the distribution shown in Fig. 
5.2 is obtained. Using this two-parameter analysis, eight cell 
compartments could be distinguished, as shown schematically in Fig. 
5.2 For detailed study of diploid (DI=1.0) and especially of 
tetraploid (DI=2.0) cells, the right angle scatter was used in place 
of the DNA peak height in some experiments. These distributions are 
shown in Fig. 5.2. 
For visualisation of the 8c (DI=4.0) compartment a 128x128 data 
field was used in place of the 64x64 field (Fig. 5.3). 
Identification of the cell populations contained in the various 
peaks was done by sorting and subsequent microscopic examination. A 
sorting window set on compartments one and two reveals round and 
elongated spermatids, respectively. Sorting of cells belonging to 
compartment 3 shows a mixture of Leydig cells, Sertoli cells and 
fibroblasts and indicates that this compartment consists mainly of 
non-cycling cells. The majority of cells seen in compartment 4 are 
binucleated cells and were identified as secondary spermatocytes. 
Other cells in this compartment were p'releptotene spermatocytes and 
some spermatogonia. Compartment 5 contains spermatogonia and 
clusters of spermatids. The two different compartments in the 4c 
region (DNA index=2.0) were identified as follows: Compartment 6 
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FIG. (5.1) DNA fluorescence distribution from a single cell 
suspension of a rat testis. Abscissa: Total fluorescence intensity; 
ordinate -.number of cells. The first two peaks ila,lb) represent 
haploid (DI =0.5) cells, the third and fourth peaks represent diploid 
(£>/-7.0) and 4c (Dl=2.0) cells, respectively. Mithramycin stain, CV 
(first peak)=3.54. Number of measured cells: 50,000. 
consists of "young" primary spermatocytes (leptotene and zygotene), 
cells with a relatively small nucleus, whereas in compartment 7 
homogeneously pachytene primary spermatocytes are observed. Cells in 
compartment 8, the 8c region (DNA index=4.0), are binucleated cells 
with typical bean-shaped nuclei and a very dense nuclear chromatin 
structure (Fig. 5.5). These cells were always present. Sorting and 
microscopic examination on the two subpopulations found with 
scatter-area analysis (Fig. 5.2) in the 2c region (DNA index=1.0) 
reveals that cells in these subpopulations were identified as 
belonging to compartment 4 and 5 and compartment 3, respectively 
(schematically shown in Fig. 5.2). The results of FCM analysis and 
quantification of the eight populations of testicular cells as well 
as their microscopic identification are summarized in Fig. 5.4. 
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FIG. (5.2) σ) Two-parameter FCM analysis of a cell suspension 
preparea from rat testis: peak amplitude of the fluorescence signal 
(ordinate) versus its total intensity integrated over time (abscissa). 
Two subpopulations are distinquished within the haploid (Dl=0.5) 
and tetraploid (DI =2.0) regions, whereas in the diploid (Dl=1.0) 
region three subpopulations are seen. b) Schematic drawing of 
the eight subpopulations shown in the scattergram of Fig. 5.2a. 
Ordinate: The peak amplitude of the fluorescence signal. Abscissa: 
Total intensity integrated over time, c) Two-parameter FCM analysis 
of rat testis cells using right-angle light scatter (ordinate) versus 
total intensity of the signal over time (abscissa). An improved 
separation of the two subpopulations in the 4c (Dl=2.0) region can 
be observed, which facilitates the sorting, identification and 
quantitation of each subpopulation d) Schematic drawing of the 
scattergram shown in Fig. 5.2b. Ordinate: right angle scatter; 
abscissa: the total intensity of the signal over time. 
Fig. 5.6 shows the cytological documentation of the different sorted 
populations. 
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FIG. (5.3) DNA fluorescence distribution from a single cell 
suspension of a rat testis using a 728x128 data field. Abscissa: 
Total fluorescence intensity; ordinate: number of cells, mithramycin 
stain, number of measured cells: 50,000. 
DISCUSSION 
The present study uses two DNA-derived FCM parameters in place of 
one to analyze the cell populations present in rat testis. The total 
cellular fluorescence integrated over time gives an accurate 
determination of total stainable DNA per cell. This is seen in Figs. 
5.1 and 5.2 and has been amply documented in the past (14). 
Differences in the state of chromatin condensation may be reflected 
in this total DNA parameter (10), and these differences as well as 
shape differences are partially responsible for the distinction 
between round and elongated spermatids seen in Fig. 5.1. The 
one-parameter histogram does not show a good resolution in the 1c 
(DI=0.5) region. In Fig. 5.4 the 6:1 ratio of round to elongated 
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Compartment. 
(*) 1 
2 
3 
4 
5 
6 
7 
β 
Sorted cell type Tota 
Round spermatids 
Elongated spermatids 
Leydig and Sertoli 
cells, fibroblasts 
Secondary and preleptotene 
spermatocytes some 
spermatogonia 
Spermatogonia and 
clusters of spermatids 
Leptotene and zygotene 
spermatocytes and some 
spermatogonia 
Pachytene primary 
spermatocytes 
Spermatocytes (?) 
il populate 
59.5 ±3.1 
10.5 ±3.4 
2.8 ±0.3 
7.5 ±0.5 
4.8 ±1.5 
1.4 ±0.3 
6.4 ±1.3 
1.0 ±0.4 
FIG. (5.4) Identification of the sorted cells and quantitation of the 
different compartments demonstrated by two-parameter DNA flow 
cytometry. (*) See Fig. 5.2b for the definition of the 
compartments. 
spermatids is inconsistent with the approximately equal numbers of 
these cells in the testis. Much better discrimination of round and 
elongated spermatids may be performed using other preparation 
protocols (6,15). 
The shape of the fluorescence signal is influenced by the nuclear 
size such that for equivalent amounts of stainable DNA (equivalent 
integrated DNA signals), larger nuclei have longer, lower 
fluorescence signals, while smaller, more condensed nuclei produce 
shorter, higher peaks. Since testicular germ cell nuclei vary 
considerably in size and shape during the various stages of 
maturation, use of the height of the DNA fluorescence signal as a 
second parameter produces useful information in FCM analysis of 
testis cells. For example, the peak in the DNA index region 1.0 in 
the histograms represents spermatogonia, preleptotene spermatocytes, 
secondary spermatocytes and non-cycling cells (Leydig cells, Sertoli 
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FIG. (5.5) Photomicrograph of an octaploid cell. Note the highly 
condensed chromatin structure. Magnification: χ 1000. Haematoxylin 
stain. 
cells, and the like). This region thus constitutes a very 
heterogeneous mixture of cell types for which a single-parameter 
histogram has little interpretative value. Using two-parameter DNA 
analysis, non-germ cells can be distinguished from germ cells in the 
2c DNA (DI=1.0) region (Fig. 5.2). This distinction allows separate 
analysis of pharmacologic effects on germ cells and other cellular 
components of normal testis, as well as on the various subsets of 
germ cells. Thus, two-parameter DNA-derived FCM analysis of testis 
cell subpopulations can provide sufficient resolution to recognize 
important effects of drugs and other manipulations on components of 
spermatogenesis (van Kroonenburgh et al, in preparation). 
Differences in condensation and arrangement of chromatin during 
maturation of spermatids allows demonstration of the two distinct 
peaks of DNA fluorescence instead of one broad one in the DNA index 
region 0.5 (4,9). The binucleated cells found in the DNA index 
region 1.0 (Fig. 5.2) are probably secondary spermatocytes. 
Compartment 8 reveals information that could not be obtained from 
histological slides. We hypothesize that these characteristic 
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FIG. (5.6) Photomicrograph of cells sorted from the eight 
subpopulations (see text). The numbers of the photomicrographs 
correspond with the number of the population as described in Fig. 
5.2. Original magnification for all photomicrographs: χ 160. 
Haematoxylin stain. 
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binucleated cells (Figs. 5.5, 5.6) are not artefacts (7), but cells 
normally present in rat testis as 1.0% of the total population. 
These 8c (DI=4.0) cells were also observed in mouse testis by Dr. U. 
Hacker, Munster, Germany (unpublished results 1983). Whether these 
cells belong to the germ cells (primary spermatocytes) or non-germ 
cells remains to be investigated. It can be concluded that 
two-parameter flow cytometry can be used as a more sensitive 
analytical tool in observing effects on spermatogenesis and can give 
more detailed information as compared to single-parameter DNA flow 
cytometry. 
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EFFECTS OF TESTICULAR IRRADIATION ON STEM CELL 
SURVIVAL, HORMONAL ENVIRONMENT AND SPERMATOGENIC 
CELLS IN WISTAR RATS 
M.J.P.G. van Kroonenburgh, W.A.J, van Daal, 
J.L. Beck, H.M. Vemer, R. Rolland and C.J. Herman 
(Submitted for publication in Acta Radiologica Oncology) 
ABSTRACT. Adult male rats were exposed to 3.0 Gy of local 
testicular irradiation. Testes of irradiated and non-irradiated 
rats were examined histologically and flow cytometrically, at 
several intervals up to 78 days after irradiation. Concentrations 
of FSH, LH and testosterone determined at these intervals were not 
different from those of controls. The survival of stem cells were 
measured 11 weeks after irradiation (with doses varying from 1.0 Gy 
to 6.0 Gy at 0.6 Gy/minute) by means of the repopulation index and 
by the number of haploid cells (spermatids). Correlation between 
both methods and relation to stem cell survival were discussed. The 
dose response curves yielded Do values of stem cell survival of 2.33 
± 0.06 Gy (repopulation index) and 2.08 ± 0.08 Gy (number of haploid 
cells). The Do value of the rat was not much different from that 
found in mice. It was concluded that the used parameters can offer 
us insight when studying hormonal substances during irradiation. 
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INTRODUCTION 
With the success of irradiation in prolonging the lives of 
patients with malignant diseases one started to realize that 
permanent gonadal damage may be induced. A treatment which could 
reduce the magnitude of testicular damage is highly desirable since 
it may result in preservation of reproductive function. 
It is known (7,8,15,28) that radioresistant stem cells play a 
crucial role in long term effects of irradiation on fertility. 
Shortly after testicular irradiation stem cell spermatogonia are 
almost the only spermatogonia present (1,9). It was suggested 
(26,28), that the sharp increase of stem cell radiosensitivity 
occuring shortly after irradiation, could be attributed to a change 
of surviving stem cells towards a much more radiosensitive phase of 
their cell cycle. From a theoretical point of view, hormones could 
be considered to be able to reduce or to avoid radiation damage, 
arresting stem cell division in the radioresistant phase, resulting 
in preservation of reproductive function. While proof of this 
hypothesis is lacking, its validity can be tested by interrupting 
the p'ituitary-gonadal axis by hormones during testicular 
irradiation. There are a number of studies which have set precedent 
in terms of protection of spermatogenesis by hormones 
(6,10,11,16,21,24). However, these studies have in general 
concentrated upon protection from cytotoxic drugs. 
Before studying if hormonal treatment during irradiation is a 
possible mechanism to protect the testis from radiation damage, 
definition of parameters are necessary. The purpose of this 
investigation was to define the radiosensitivity of stem cells and 
to study the effects of irradiation on hormonal, histological, and 
flow-cytometrical parameters. 
MATERIALS A N D METHODS 
The experiments were started with 3-months-old male outbred 
Wistar rats (Cpb:WU) each weighing about 300 g. The animals were 
allowed free access to dry pellet food (RMH-TM HOPE-FARMS, Woerden, 
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The Netherlands) and tap water. They were housed in groups of 4 in 
well ventilated cages at 220C with a day/night rhythm of 12 hours. 
24 rats were used to measure the Do value of stem cell survival. 
Groups of 4 rats each were irradiated with 0 (controls), 1.0, 2.0, 
3.0, 4.0 and 6.0 Gy and killed 11 weeks after irradiation. 36 
Wistar rats were used to study the local effect of 3.0 Gy testicular 
irradiation dose and were divided into two groups consisting of 18 
rats each. Group 1 was given a single dose of testicular irradiation 
dose of 3.0 Gy, whereas Group 2 received the same procedure except 
no irradiation was given (controls). Serum hormone concentrations, 
number of tetraploid and haploid cells and testicular histology were 
quantified at day 0, 7, 14, 21, 28, 39, 52, 65, 78 after 
irradiation. Blood was collected by heart puncture and after 
centrifugation (1200g, 10 min) serum samples were stored at -20°C 
until analysed. The testes were removed and weighed immediately 
after heart puncture. 
Irradiation conditions 
The rats were anaestized with an Alyrane 
(2-chloor-l,1,2-trifluorethyl-difluor methylether) oxygen gas 
mixture and irradiated in prone position with the 18 MV photon beam 
of a Saturne linear accelerator (CGR, BUG, France). The Saturne is 
equipped with a mercury shielded irregular field system device (2) 
which was used to define 4 irradiation portals of 4x5 cm each, so 
that 4 rats could be irradiated on their scrotum simultaneously. To 
achieve a dose homogeniety in the target volume within 10% it was 
necessary to get rid of the build region in the beam. Therefore a 
1.5 cm thick plexiglas plate was positioned just above the rats. The 
dose rate during the experiments was 0.6 Gy/minute. 
Stemcell survival assays 
Spermatogonia! stem cell survival was evaluated by the 
repopulation index (RI) and by counting the number of haploid cells 
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(spermatids) by using flow cytometry. The left testis from each 
killed animal was fixed in Bouin's fluid and embedded in paraffin 
wax. From each testis three sections, separated from each other by a 
distance of 500 ym, were taken from the midportion of the testis and 
stained with Periodicacid-Schiff (PAS). The percentage of tubulus 
which showed spermatogenic repopulation in histological sections, 11 
weeks after irradiation, was defined as the the repopulation index 
(25). A tubules was considered to repopulate when it contained at 
least one spermatogonium. The right testis was used for flow 
cytometric analysis. Radiosensivity can be estimated by the dose 
required to reduce survival to 37% of the initial value on the 
straight-line portion of a survival curve (Do value). The Do value 
of the curve was calculated with a linear regression model by a 
simple least-square analysis at the mean RI values as was previously 
described (25). 
Histology 
The left testis from each animal was fixed in Bouin's fluid, 
dehydrated in 70% ethanol and embedded in paraffin wax. Duplicate 
transverse sections of Sym were taken from the midportion of the 
testis and stained with Periodicacid-Schiff (PAS) with and without 
prior diastase digestion. For histological measurement, the germ 
cell maturation sequence of 14 stages as proposed by Leblond and 
Clermont (20), was used. The counts were made on cross sections of 
25 seminiferous tubules. The numbers of spermatogonia or 
preleptotene spermatocytes were expressed as numbers per 100 Sertoli 
cells. Expressing the data in this way corrects for tissue shrinkage 
and permits a comparison of germ cell counts from one time interval 
to another. Spermatogonia of types Ao and Al were scored as a single 
class of cells since in our material they could not be 
differentiated. Type В spermatogonia were scored at stage 6; 
intermediate spermatogonia at stage 3 and preleptotene spermatocytes 
at stage 8 of the cycle. 
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Flow cytometry 
The right testis from each animal was dissected free from fat and 
connective tissue. To obtain a fluorescent stained single cell 
suspension, preparation and staining procedure was caried out as 
previously described (18). Haploid and tetraploid cells were 
measured by flow cytometric analysis which was performed on an Ortho 
System 50-H (Ortho Instruments; Westwood, MA, U.S.A) using the 457 
nm line of the argon ion laser (Spectra Physics, Mountain View, CA, 
U.S.A) at 200 mW power. 
Hormone measurements 
Serum concentrations of follicle-stimulating hormone (FSH) and 
luteinizing hormone (LH) were measured by double-antibody solid 
phase radioimmunoassays using the rat gonadotrophin kit reagents 
supplied by NIADDK, Bethesda, MD, U.S.A. The measurements were 
expressed as iig/1 in terms of the NIADDK-rat FSH-RP-1 and LH-RP-1 
standards, respectively. The minimum detectable concentrations were 
10 pg LH/1 and 50 vg FSH/1. The precision was 5.9% within assays 
and 6.7% between assays for duplicate measurements of FSH in a serum 
pool (mean value 264 pg/l) in 15 consecutive assays. For LH these 
values were, respectively, 3.9% and 9.6% (mean: 59 yg/l) in 15 
consecutive assays. Testosterone was measured by a dextran-coated 
charcoal radioimmunoassay after extraction of serum samples with 
diethyl ether. The antiserum used was raised in a rabbit and 
directed against Testosterone-3-(0-carboxymethyl)-oxime-BSA. The 
sensitivity of the assay was 0.1 nmol/l and the precision, as 
calculated from a serum pool (mean value: 1.85 nmol/l) after 14 
consecutive measurements), was 3.9% within assays and 5.7% between 
assays. 
Statistical analysis was performed by using the two-side 
Mann-Whitney U test. Differences were considered to be 
statistically significant when P< 0.05. 
61 
CHAPTER 6 
RESULTS 
A semilogarithmic plot of the percentage of stem cell survival 
versus radiation exposure was determined from the RI (Fig. 6.1) and 
from the number of haploid cells (Fig. 6.2). In view of the better 
multiple correlation coefficient, the data point of 1.0 Gy was 
excluded. The regression analysis, without the 1.0 Gy data points 
yielded (mean ± s.d.) Do values of 2.33 ± 0.06 Gy (RI) and 2.08 ± 
0.08 Gy (haploid cells). The logarithm of the RI was a linear 
function of dose (multiple correlation coefficient >.95). The data 
points of both methods (expressed as fractions of controls) were not 
significant (P<0.05) different from each other. The η value 
(extrapolation number) was 167 (RI) and 2.12 (number of haploids as 
-i 1 1 1 1 τ­
ι.· ι.· a.· 4.· M ·.· 
FIG. (6.1) Stem cell survival as measured by the repopulation 
index, 11 weeks after irradiation with different dosages. Values are 
mean ± s.d. of U rats. 
a fraction of controls). 
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The effect of 3.0 Gy single dose irradiation on testes weight, 
the number of spermatogonia and preleptotene spermatocytes and on 
the serum concentrations of FSH, LH and testosterone are presented 
in Fig 6 3. Testes weight declined to 50% of those of control 
value at day 39 As a result of this irradiation dose a large 
fraction of type A, intermediate and Type В spermatogonia and 
FIG. (6.2) Stem cell survival as measured by the number of haploid 
cells, 11 weeks after irradiation with different dosages. Values are 
mean ± s.d. of 4 rats. 
preleptotene spermatocytes were rapidly destructed (Fig. 6 3). 
Recovery was seen from day 14 on. The numbers of type 
intermediate spermatogonia showed an overshoot phenomenon. The 
elimination of spermatogonia resulted in a progressive disappearance 
of the numbers of tetraploid and haploid cells (Fig. 6.3). The total 
number of spermatids dropped to IO"» of the control value. It can be 
seen (Fig. 6.3), that recovery of spermatids after 3.0 Gy local 
irradiation commenced after 52 days. The concentrations of FSH, LH 
and testosterone were equal to that of controls at each time 
interval (Fig. 6.3). 
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FIG. (6.3) Effect of a single dose irradiation of 3.0 Cy on (mean t 
range) testicular weight (A), on the numbers per 100 Sertoli cells 
of type A (fl), Intermediate (C) and type В spermatogonia (D) and 
preleptotene spermatocytes (Ε), on the number of tetra pi oid cells 
(F; mainly pachytene spermatocytes), on the number of haploid 
cells (C; spermatids) and on the serum hormone concentrations of 
FSH (Η), LH (I) and testosterone (J) in adult rats. 
DISCUSSION 
Two assays for testicular stem cell survival have been aplied to 
obtain survival curves. The number of clones in the testis found 
several weeks after irradiation have been described (25,29) as a 
direct measurement of stem cell survival. Because there is also a 
quantitative correlation (22) between testicular stem cell survival 
and sperm production and since haploid cells are corresponding only 
to spermatids and to no other testicular cells, the number of 
haploid cells as measured by flow cytometry can also be used as a 
measurement of stem cell survival (12). The relationship between 
spermatid production and stem cell number may be linear. However, 
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for the mouse, Meistrich (22) has demonstrated that although sperm 
production and stem cell survival as measured by RI were highly 
correlated the relationship was not linear (the regression line had 
a slope of 1.7 on a log versus log plot). The evaluation of the 
radiosensitivity of stem cells shows a good parallel between both 
stem cell assays in the actual dose range. Our results are, however, 
in contrast with those of others. Clow and Gilette (3) and Erickson 
(8), found Do values of 3.80 Gy and 3.73 Gy, respectively. A 
comparison of the reported Do values for mice in literature by 
Ruiter-Bootsma et al. (26) and Withers et al. (28), indicates that 
our Do value of the rat is not much different from that found in the 
mouse (2.4 Gy and 1.8 Gy). This is in accordance with the fact that 
the dose required to produce infertility (13,17) in the mouse is the 
same as that in the rat. However, in the low dose range when the 
repoplation index exceeds the value of 0.5, the assay reliability is 
controversial as multicellular origin of colonies can not be 
excluded. Correction must therefore be made for the possibility of 
clone confluence (23). If so, the corrected mean Do value of the RI 
values was even lower (1.8 Gy). 
Since spermatogonia are so very radiosensitive (1,7), a 
maturation depletion occurs of other spermatogenic cells in their 
order of developmental sequence, eventually resulting in loss of 
sperm. This is clearly shown by the decrease in number of 
preleptotene and pachytene spermatocytes (the numbers of tetraploid 
cells are mainly consisting of pachytene spermatocytes (19)) and by 
the low numbers of spermatids (number of haploid cells) from day 39 
till day 52. This decrease in the number of pachytene spermatocytes 
and spermatids was not parallelled by an alteration in serum hormone 
concentrations Studies (5,14) showed an increase in serum FSH 
depending on the used dose of irradiation. Conflicting results have, 
however, been reported after a irradiation dose of 3.0 Gy. 
Cunningham and Huckins (4) and Verjans and Eik-Nes (27) showed no 
alteration in FSH levels, whereas Hopkinson et al (14) did. Our 
findings agree with the findings of Cunningham and Huckins (4), that 
the selective abscence of spermatogonia and spermatocytes do not 
affect serum hormone concentrations. From our results we conclude 
that the used parameters offers us insight when studying hormonal 
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substances during irradiation. This will be the subject of a 
subsequent report. 
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EFFECTS OF DANAZOL ON SPERMATOGENESIS IN ADULT RATS 
M.J.P.G. van Kroonenburgh, J.L. Beck, H.M. Vemer, 
C.M.G. Thomas, R. Rolland and C.J. Herman 
(Published in Journal of Reproduction and Fertility 77,233-238, 1986) 
ABSTRACT. Adult male Wistar rats were treated with Danazol (A 
mg/day s.c.) for 52 days. The drug produced a marked, rapid drop in 
serum testosterone concentrations to very low levels and caused a 
slower decrease in serum FSH, LH and testis weight. Flow cytometric 
analysis of testicular cell suspensions showed a decline in the 
absolute numbers of haploid cells (spermatids), tetraploid cells 
(mainly pachytene spermatocytes) and of cells in the S-phase of the 
division cycle, suggesting that Danazol inhibited proliferation of 
spermatogonia and/or primary spermatocytes. Histological counting 
of the different types of spermatogonia, however, revealed no 
significant change in their numbers during Danazol treatment. It is 
concluded that Danazol inhibited spermatogenesis primarily after the 
preleptotene stage of primary spermatocytes. 
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INTRODUCTION 
Danazol (a 2,3-isoxazol derivative of 17-a-ethinyl-testosterone) 
has been described as an active pituitary gonadotrophin inhibitory 
agent, suppressing the pituitary-gonadal axis in animals 
(2,3,4,5,11,12) and in man (10,14,15,17). Danazol appeared to 
suppress spermatogenesis by depletion of spermatocytes, spermatids 
and spermatozoa (14), but the stage or stages of spermatogenesis 
which are affected have not yet been defined. Ulstein et al. (17) 
suggested that Danazol acts by inhibiting spermatogenesis at the 
spermatocyte/spermatid level. In most studies (3,5,11), animals 
without functional gonads or immature rats were used to assess the 
antigonadotrophic properties of Danazol. According to Barbieri et 
al. (1), these studies are not directly applicable to animals with 
intact gonadal function. At all tested doses (1.25-10 mg/kg s.c.) of 
Danazol in male rat, serum LH and FSH concentrations were 
unsuppressed, whereas the suppression of serum testosterone appeared 
to be dose-dependent (1). 
The purposes of the present investigation were (1) to study the 
antigonadotrophic effects of Danazol in intact mature male rats by 
measuring serum gonadotrophin concentrations, and (2) to examine the 
effect on the different steps of spermatogenesis by counting the 
different types of spermatogonia. In earlier published reports 
(3,5,11) Danazol had antigonadotrophic effects in rats at a dosage 
of 4 mg s.c. given daily, and so this dose was used throughout the 
present study. 
MATERIALS A N D M E T H O D S 
The experiments were started with 3-month-old male outbred Wistar 
rats (Cpb:WU) with a body weight of about 300 g. The animals were 
allowed free access to dry pellet food (RMH-TM HOPE-Farms, Woerden, 
The Netherlands) and tap water. They were housed in groups of 4 in 
well ventilated cages at 22°C with a day/night rhythm of 12 h. The 
42 rats received daily ( at 09:00 h) s.c. injections of 4 mg Danazol 
70 
(Steriing-Winthrop Research Institute, London, U.K.) suspended in 
0.2 ml sesame oil. Groups of 6 rats were killed at 10:00 h under 
ether anaesthesia before the injection (controls) and at 7, 14, 21, 
28, 39 and 52 days after the start of drug injections. Blood was 
collected by heart puncture and the testes were removed immediately 
and weighed. After centrifugation (1200 g, 10 min), serum samples 
were stored at -200C until analysed. 
Hormone measurements 
Serum concentrations of follicle-stimulating hormone (FSH) and 
luteinizing hormone (LH) were measured by double-antibody 
solid-phase radioimmunoassays using the rat gonadotrophin kit 
reagents kindly supplied by NIAMDD, Bethesda, Maryland, U.S.A. The 
measurements were expressed as ng/ml in terms of the NIAMDD-rat 
FSH-RP-1 and LH-RP-1 standards, respectively. The minimum detectable 
concentrations were 10 ng LH/ml and 50 ng FSH/ml. The precision was 
5.9% within assays and 6.7% between assays for duplicate 
measurements of FSH in a serum pool (mean: 264 ng/ml in 15 
consecutive assays). For LH these values were, respectively, 3.9% 
and 9.6% (mean: 59 ng/ml in 15 consecutive assays). Testosterone 
was measured by a dextran-coated charcoal radioimmunoassay after 
extraction of serum samples with diethyl ether. The antiserum used 
was raised in a rabbit and directed against 
testosterone-3-(0-carboxymethyl)-oxime-BSA. The sensitivity of the 
assay was 0.1 ymol/ml and the precision, as calculated from a serum 
pool (mean value: 1.85 ymol/ml after 14 consecutive measurements) 
was 3.9?i within assays and 5.7% between assays. 
Histology 
The left testis from each animal was fixed in Bouin's fluid, 
dehydrated in 70% ethanol and embedded in paraffin wax. Duplicate 
transverse sections of 5 ym were taken from the midportion of the 
testis and stained with periodicacid-Schiff (PAS) with and without 
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prior diastase digestion. For histological measurement, the germ 
cell maturation sequence of 14 stages as proposed by Leblond and 
Clermont (8), was used. The counts were made on cross-sections of 25 
seminiferous tubules. The numbers of spermatogonia or preleptotene 
spermatocytes were expressed as numbers of cells per 100 Sertoli 
cells. Expressing the data as numbers of cells per 100 Sertoli cells 
corrected for tissue shrinkage and permitted a comparison of germ 
cell counts from one time interval to another. Spermatogonia of 
types Ao and Al were scored as a single class of cells since in our 
material they could not be differentiated. Type В spermatogonia were 
scored at stage 6; intermediate spermatogonia at stage 3 and 
preleptotene spermatocytes at stage 8 of the cycle. 
Flow-cytometry 
The right testis from each animal was dissected free from fat and 
connective tissue. After decapsulation, the tissue was minced 
carefully with scissors in 15 ml phosphate buffer (pH 7.4; 23.8 mg 
PO^'- /ml) and sieved through a 50 pm mesh filter. All preparation 
steps were done at room temperature. This cell suspension was passed 
through a 25-gauge, 25 mm needle, centrifuged at 370 g for 10 min 
and the cell pellet resuspended in 10 ml phosphate buffer by 
vortexing. Debris was removed by filtration through a nylon filter 
(pore size: 50 μιη). The suspension was again centrifuged at 370 g 
for 10 minutes and the supernatant discarded. Samples were fixed in 
50% ethanol (-200C) and stored at 40C until analysed. Staining was 
carried out as described elsewhere (6,16). Briefly, 1 ml cell 
suspension (about 3 χ 10* cells) was centrifuged for 10 min at 370 g 
and the ethanol wasdiscarded. The cell pellet was resuspended in 1 
ml staining solution consisting of 0.1 mg Mithramycin (Serva Fein 
Biochemica, Heidelberg, W. Germany) per ml 15 mM-MgCl2 in 0.85% 
NaCl (w/v). Staining was carried out in the dark at room temperature 
for 30 min. Flow-cytometric analysis was performed on an Ortho 
System 50-H (Ortho Instruments; Westwood, MA, U.S.A.) using the 457 
nm line of the argon ion laser at 200 mW power. A Coulter counter 
was used to count the number of cells in 1 ml of the cell 
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suspension. The total cell counts per volume were needed for 
calculation of the total number of the different cell types in the 
testis. 
Statistical analysis was performed by using the two-sided 
Mann-Whitney U test. Differences were considered to be 
statistically significant when Ρ <0.05. 
RESULTS 
Serum hormone concentrations 
There was a significant decrease of serum FSH, LH and 
testosterone concentration after 7 days of Danazol treatment 
(P<0.05), which persisted throughout the period of Danazol 
administration (Fig. 7.1). Also a significant (P<0.05) decrease in 
total testicular weight was observed (Fig. 7.2) after 39 days of 
drug administration. 
Germ cell populations 
No significant effects of Danazol on the numbers of the different 
types of spermatogonia or on the numbers of preleptotene primary 
spermatocytes were detected (Fig. 7.3). 
Proliferative activity of testicular cells 
An example of a flow-cytometric histogram of untreated testicular 
cells is presented in Fig. 7.4. The two subpeaks in the 1С region of 
the histogram represented round (la) and elongated (lb) spermatids 
respectively. The geometry of the histograms was symmetrical and 
distributions were obtained with a coefficient of variation of 3.5% 
(1С peak). 
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FIG. (7.1) The effects of Danazol (4 mg/day s.c.) on serum 
concentrations of (α) FSH, (b) LH and (c) testosterone in adult 
male rats. Values are mean ± s.d. for 6 rats /group. 
A decrease of total number of haploid cells was observed (P<0.05) 
after 28 days of treatment (Fig. 7.5) and an almost parallel decline 
of tetraploid cells occurred (Fig. 7.5). A significant decrease 
(P<0.05) of the number of cells in the S-phase (Fig. 7.5) was seen 
after 39 days of Danazol administration. 
DISCUSSION 
It is apparent from the present study that Danazol effectively 
suppresses the pituitary-gonadal axis in adult rats. In our study a 
significant decrease of gonadotrophins occurred (P<0.05) within 7 
days of Danazol treatment at a dose of U mg/day s.c. From these 
data it appears that Danazol treatment of animals with intact 
gonadal function is accompanied by lowered hormone concentrations 
(1). Histological counting showed no significant influence of 
Danazol treatment on the different types of spermatogonia. This 
supports the evidence that anti-gonadotrophic treatments have 
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FIG. (7.2) The effect of Danazol (4 mg/day s.с.) on mean ± s.d. 
testicular weights of adult rats {61group). 
similar effects on the specific stages of spermatogenesis (13). Of 
special interest, however, is the quantitative analysis of changes 
in proliferative activity of testicular cells in animals receiving 
Danazol. In normal spermatogenesis the last duplication of DNA takes 
place in the S-phase of a primary spermatocyte (9). The number of 
cells in the S-phase therefore reflects the proliferative activity 
of cells in the early stages of spermatogenesis. From the decrease 
of cells in the S-phase during Danazol administration (Fig. 7.5), it 
can be concluded that the drug influenced the proliferative activity 
of spermatogonia and/or primary spermatocytes, either directly or 
indirectly. Whether this was due to a decrease in spermatogonia or 
in preleptotene spermatocytes, or both remains to be investigated. 
Tetraploid cells consisted mainly of pachytene spermatocytes and 
only to a lesser degree of spermatogonia in mitosis (7). Finally, 
during Danazol treatment a drop in total numbers of cells takes 
place. (Fig. 7.5). The uncoupling of the effects on the total number 
of cells in the S-phase from effects on gonadotrophin concentrations 
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Days 
FIG. (7.3) The numbers (mean t s.d.) of the different types of 
spermatogonia, A (d), intermediate (b), and В (с), and 
preleptotene primary spermatocytes (a) per 100 Sertoli cells. 
suggests that, at least initially, the early stages of 
spermatogenesis are relatively independent of serum concentrations 
of FSH, LH and testosterone. 
It can be concluded that Danazol suppresses serum concentrations 
of gonadotrophins in intact adult male rats and inhibits 
spermatogenesis from the preleptotene stage of the primary 
spermatocyte onwards. It also has a direct or indirect inhibiting 
effect on the proliferation of spermatogonia and/or primary 
spermatocytes. 
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FIG. (7.4) DNA fluorescence distribution from a single cell 
suspension of a rat testis. Abscissa: total fluorescence intensity; 
ordinate: number of cells (counts). The first two peaks (la,lb) 
represent haploid cells (round and elongated spermatids 
respectively), the third (2c) and fourth (4c) peaks represent 
diploid and tetraploid cells, respectively. Mithramycin stain, 
Variation coefficient (first peak)= 3.5%. 
77 
CHAPTER 7 
FIG. (7.5) Mean ± s.d. absolute numbers of (α) haploid 
{spermatids) cells, (b) tetraploid {mainly pachytene primary 
spermatocytes) cells and (c) in the S-phase of the division cycle 
per testis during 52 days of continous treatment with Danazol {4 
mg I day s.c.) in adult rats {6/group). 
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EFFECTS OF A SINGLE INJECTION OF A NEW DEPOT 
FORMULATION OF AN LH-RELEASING HORMONE AGONIST ON 
SPERMATOGENESIS IN ADULT RATS 
M.J.P.G. van Kroonenburgh, J.L. Beck, H.M. Vemer, 
R. Rolland, С.M.G. Thomas and C.J. Herman 
(Accepted for publication in the Journal of Endocrinology) 
ABSTRACT. Adult male Wistar rats were treated with a single 
injection (500 vg s.c.) of a new biodegradable depot formulation of 
the LH-releasing (LHRH) analogue D-Ser(But)G, AzGly10-LH-RH (Zoladex 
ICI 118630) to evaluate its potential for inhibiting 
spermatogenesis. The drug produced a marked (P<0.05) decrease in 
serum concentrations of FSH, LH and testosterone with a maximum 
effect 14 days after treatment. Since striking focal histological 
changes were seen in the testis after only 1 week, at a time when 
changes in serum gonadotrophins were minimal, there may be a direct 
effect of the LHRH analogue on spermatogenesis. Degenerative changes 
in germ cells as well as Sertoli cells could be observed. Flow 
cytometric analysis of testicular cell suspensions showed a 
significant decline in the absolute numbers of haploid cells 
(spermatids), tetraploid cells (mainly pachytene spermatocytes) and 
of the numbers of cells in the S-phase of the cell cycle. This 
suggests that the drug also inhibit proliferation of spermatogonia 
and/or primary spermatocytes. Testis weight, serum hormone 
concentrations, and histological and cytological parameters returned 
to essentially normal values 52 days after the injection. It is 
concluded that this new method of administration may have practical 
and pharmacokinetic advantages for the purpose of reversible 
inhibition of spermatogenesis. 
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INTRODUCTION 
After the discovery of the structure of luteinizing hormone 
releasing hormone (LHRH) (16) a large series of more potent 
analogues, were synthesized and investigated (4). Originally, it was 
thought that these analogues would offer a new therapeutic approach 
to the treatment of infertility, but it was soon realized (7,12) 
that they also cause desensitization of the pituitary gland, 
creating a hypogonadotrophic state. As a consequence, the LHRH 
analogues were investigated for the purpose of male contraception 
(15). Recently, the LHRH analogue Zoladex (D-Ser(But)s, 
AzGlyl0-LH-RH), has been developed. It is available as a depot 
formulation, in which the LHRH analogue is dispersed throughout a 
matrix of d,1-lactide-glycolide co-polymer (9). When injected s.c, 
the co-polymer slowly degrades and the LHRH analogue is released 
into the subcutaneous tissue and absorbed into the systemic 
circulation. This formulation has both practical and pharmacokinetic 
advantages over daily injections. 
The purpose of the present study was to investigate the 
inhibitory effect of a single s.c. injection of Zoladex depot on 
spermatogenesis as well as the reversibility of any changes 
observed. In addition, follicle-stimulating hormone (FSH), 
luteinizing hormone (LH) and testosterone concentrations were 
measured before and after Zoladex treatment. Counting of 
spermatogonia and preleptotene 'spermatocytes in histological 
sections allowed an assessment to be made of which step(s) in 
spermatogenesis were affected. Finally, flow cytometric analysis 
was used to determine the proliferative behaviour of testicular 
cells after the depot injection. 
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MATERIALS AND METHODS 
Animals and treatments 
Three-month-old male outbred Wistar rats (Cpb:WU) with a body 
weight of about 300 g were used. They were allowed unrestricted 
access to dry pelleted food (RMH-TM HOPE-Farms, Woerden, The 
Netherlands) and tap water, and housed in groups of four in 
well-ventilated cages at 220C with a day/night light cycle of 12. At 
the beginning of the experiment 42 rats received a s.c. depot of 
Zoladex (ICI PLC, Pharmaceuticals Division, Macclesfield, 
Cheshire), this consisted of a cylindrical rod (approximately 3 mm 
long) containing 500 vg LHRH analogue. Six rats were killed at 10.00 
h under ether anaesthesia on days 0 (controls), 7, 14, 21, 28, 39 
and 52 after injection of the drug. Blood was collected by heart 
puncture and the testes were removed immediately and weighed. After 
centrifugation (1200 g, 10 min) the serum was stored at -200C until 
assayed. 
Hormone measurements 
Serum concentrations of FSH and LH were measured as previously 
described by Van Geelen et al.(23) by double-antibody solid phase 
radioimmunoassays using the rat gonadotrophin kit reagents kindly 
supplied by NIADDK, Bethesda, MD, U.S.A. Measurements are expressed 
as yg/l in terms of the NIADDK-rat FSH-RP-1 and LH-RP-1 standards, 
respectively. The minimum detectable concentrations were 10 yg LH/1 
and 50 vg FSH/1. The precision was 5.9% within assay and 6.7% 
between assays for duplicate measurements of FSH in a serum pool 
(mean value 264 yg/1) in 15 consecutive assays. For LH these values 
were 3.9 and 9.6%, respectively, (mean: 59 yg/l) in 15 consecutive 
assays. Serum testosterone concentrations were measured by a 
dextran-coated charcoal radioimmunoassay after extraction with 
diethyl ether and subsequent isolation of the testosterone fractions 
by Sephadex LH-20 (Pharmacia Fine Chemicals AB, Uppsala, Sweden) 
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column chromatography, using antisera raised in rabbits and directed 
against testosterone-3-(0-carboxymethyl)-oxime- bovine serum 
albumin. Tritiated [1,2,6,7,16,17-H3] testosterone (New England 
Nuclear, Boston, MA, U.S.A.) was used as a radioactive label, while 
testosterone from Sigma Chemical Company, St. Louis, MO, U.S.A., was 
used in the range from 0.01 to 15 nmol per tube as the standard 
preparation. The sensitivity of the assay was 0.1 nmol/1 and the 
precision as calculated from a serum pool (mean value: 1.85 nmol/1) 
after 14 consecutive measurements, was 3.9% within assay and 5.7% 
between assay. 
Histology 
The left testis from each animal was fixed in Bouin's fluid, 
dehydrated in 70% ethanol and embedded in paraffin wax. Duplicate 
transverse sections of 5 urn were taken from the mid-portion of the 
testis and stained with Periodic acid-Schiff reagent with and 
without prior diastase digestion. For histological measurement we 
used the germ cell maturation sequence of 14 stages as proposed by 
Leblond and Clermont (14). The counts were made on cross sections 
of 25 seminiferous tubules. The numbers of spermatogonia and 
preleptotene spermatocytes were expressed as numbers per 100 Sertoli 
cells. Expressing the data this way corrected for tissue shrinkage 
and permitted a comparison of germ cell counts from one time 
interval to another. Spermatogonia of types Ao and Al were scored as 
a single class of cells since in our material they could not be 
differentiated. Type В spermatogonia were scored at stage 6; 
intermediate spermatogonia at stage 3 and preleptotene spermatocytes 
at stage 8 of the cycle. 
Flow-cytometry 
The procedure used was similar to that described previously by 
van Kroonenburgh et al. (10). The right testis from each animal was 
dissected free from fat and connective tissue. After decapsulation, 
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the tissue was finely minced with scissors into 15 ml phosphate 
buffer (pH=7.4; 23.8 mg phosphate/ml) and sieved through a 50 ym 
mesh filter. The mincing and preparations were carried out at room 
temperature. This cell suspension was passed through a 25-gauge, 2.5 
cm needle, centrifuged (370xg) for 10 min, and resuspended in 10 ml 
phosphate buffer by vortex mixing. Debris was removed by filtration 
through a nylon filter (pore size: 50 ym). The suspension was again 
centrifuged (370xg) for 10 min and the supernatant discarded. All 
aliquots were fixed in 50% ethanol (-200C) and stored at 40C until 
analysis. To obtain a fluorescent stained single cell suspension, 
the staining procedure was caried out in the dark at room 
temperature for 30 min, as previously described by Hamilton et al. 
(6) Briefly, 1 ml of cell suspension (about 3xl06 cells) was 
centrifuged for 10 min (360xg) and the ethanol discarded. The cell 
pellet was resuspended in 1 ml staining solution consisting of 0.1 
mg mithramycin (MM: Serva Fein Biochemica, Heidelberg, F.R.G.) per 
ml of 15mmol MgCl2/l in 0.85% NaCl. Flow cytometric analysis was 
performed on an Ortho System 50-H (Ortho Instruments; Westwood, MA, 
U.S.A.) using the 457-nm line of the argon ion laser (Spectra 
Physics, Mountain View, CA, U.S.A.) at 200 mW power. The amount of 
DNA per cell can be expressed as the c-value, representing the 
amount of DNA in a gamete. 
Statistical analysis was performed by the Kruskal-Wallis one-way 
analysis of variance to decide whether differences between the 
groups were statistically significant. The H values obtained were 
corrected for ties. If the level of significance was <0.05, the 
Mann-Whitney 'U'-test was performed to make single comparisons with 
pretreatment values. Differences were considered to be statistically 
significant when P<0.05. 
RESULTS 
The testis weights after a single s.c. injection of a 500 yg 
Zoladex depot are shown in Fig. 8.1. No significant decrease in 
total testicular weight after drug administration was observed. 
85 
CHAPTER 8 
Zoladex caused a statistically significant decrease in serum FSH, LH 
and testosterone concentrations, with a maximum effect at day 14 
followed by a rapid increase, especially for FSH (130% compared with 
control value), to a maximum on day 28. Thereafter all values 
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FIG. (8.1) Effects of a single s.c. depot containing 500 vg Zoladex 
given at zero time on the weight of testes in adult rats. Values 
are mean ± s.d. for six rats/group. 
decreased somewhat (Fig. 8.2). 
One week after drug administration, degenerative necrotic changes 
of germ cells as well as Sertoli cells were observed. Some tubules 
showed disorganization of sperm maturation, disruption of cellular 
association or total absence of germ cells with preservation of 
Sertoli cells, whereas other tubules in the same area showed 
completely normal spermatogenesis (Fig. 8.3). 
After 14 days, many tubules showed disruption of cellular 
association and the tubules were smaller than normal with a greater 
space between individual tubules, suggesting interstitial oedema. 
The cellular disruption made quantification using the criteria 
proposed by Leblond and Clermont (14) impossible between days 7 and 
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FIG. (8.2) Effects of a single s.с. depot containing 500 yg Zoladex 
given at zero time on mean ± s.d. serum concentrations of FSH 
(upper panel), LH (middle panel) and testosterone (lower panel) in 
adult male rats (six/ group). 
39. No significant difference was observed between the control 
numbers of spermatogonia and preleptotene spermatocytes and the 
numbers of spermatogonia and preleptotene spermatocytes as found on 
day 52. Mean control numbers (± S.E.M.) of type A, intermediate and 
type В spermatogonia and of preleptotene spermatocytes per 100 
Sertoli cells were respectively 10 ± 1, 58 ± 5, 94 ± 12 and 150 ± 
10. Two weeks after Zoladex administration, white plaques of 
approximately 10 mm diameter were seen in the testes. This was 
caused by necrotic degenerative changes and/or calcification of 
seminiferous tubules. In addition many multinucleate giant cells 
(Fig. 8.3) were seen in the seminiferous tubules. During the whole 
study there were no obvious morphological changes in Leydig cells. 
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FIG. (8.3) Testicular morphology of an adult rat, 7 days after 
administration of a depot containing formulation 500 vg Zoladex (ICI 
118630). (Stained with periodic acid-Schiff reagent. Magnification: 
135x). Some tubules showed degenerative changes, whereas other 
tubules showed completely normal spermatogenesis. Note the 
multinucleated giant cells (.'). These cells are associated with 
degenerative changes of spermatids. 
An example of a flow cytometric histogram of untreated testicular 
cells is presented in Fig. 8.4. 
The two subpeaks in the 1С region of the histogram represent 
round (la) and elongated (lb) spermatids respectively (10). The 
geometry of the histograms was symmetrical and distributions were 
obtained with a coefficient of variation of 3.5%. The two subpeaks 
in the 1c region of the histogram represent round (la) and elongated 
(lb) spermatids, respectively. The peak in the 2c region represents 
diploid cells: spermatogonia, preleptotene spermatocytes and 
non-germ cells such as Sertoli cells, Leydig cells, fibroblasts, 
endothelial cells and macrophages. The peak in the 4c region 
(tetraploid cells) consists mainly of pachytene spermatocytes (11). 
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FIG. (8.4) DNA fluorescence distribution from a single cell 
suspension of a rat testis. The first peak (7c) represents haploid 
cells and consist of two subpeaks la and lb which represent round 
(7σ) and elongated spermatids (lb). The second (2c) and third (4c) 
peaks represent diploid and tetraploid cells, respectively. Cells 
were stained with mithramycin. 
Fig. 8.5 presents the total number of haploid cells and tetraploid 
cells and the number of cells in the S-phase. A decrease (P<0.05) in 
total number of haploid cells to 25% of that of controls was 
observed from day 14 to day 39 after drug administration, almost 
parallelling a decline in tetraploid cells. A significant (P<0.05) 
decrease in the number of cells in the S-phase to 50% of those of 
controls was observed only at day 28. Flow cytometric values 
returned after day 28 to become essentially normal by day 52. 
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FIG. ( 8 . 5 ) Mean ( t s.d.) absolute numbers of haploid (1c) cells 
(spermatids; upper panel), tetraploid (Qc) cells (mainly pachytene 
primary spermatocytes; middle panel) and cells in the S-phase of 
the cell cycle (lower panel) per testis after administration of a 
single depot containing 500 \ig Zoladex. There were six rats per 
group. 
DISCUSSION 
The mechanism responsible for the paradoxical inh ib i tory ef fect 
of LHRH analogues on spermatogenesis appears t o be r e l a t e d to t h e i r 
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direct desensitizing effect on the pituitary gland (18). This 
results in the suppression of LH and FSH release. After 
administration of the new depot formulation of the LHRH agonist 
Zoladex, a marked fall in circulating concentrations of 
gonadotrophins and testosterone was observed. These findings are in 
contrast with chronic treatment with LHRH analogues in the rat as 
reported previously. In those studies (5,7) serum concentrations of 
testosterone were decreased in the presence of normal or even 
increased serum LH concentrations. These data suggested that the 
inhibition of testosterone secretion was caused by initial 
hyperstimulation of LH, which in turn would lead to secondary 
down-regulation of testicular LH receptors, thereby decreasing 
testicular steroidogenesis. Our studies indicate a primary effect of 
chronic analogue treatment at the pituitary level. However, direct 
effects on steroidogenesis (2,5,13) or on testicular LH and 
prolactin receptors (1,21) are still possible. The sharp increase in 
gonadotrophin concentrations at day 28 (Fig. 8.2) with a tendency to 
overcompensate was probably due to release of pituitary FSH and LH 
as the pituitary gland is released from the desensitizing effect of 
the LHRH analogue after the depot became exhausted. In order to 
achieve complete suppression of gonadotrophins, repeat injections of 
Zoladex in this dosage at 21 day intervals may be necessary. 
The histological and cytological changes observed are 
interesting. During the period when FSH and LH concentrations were 
suppressed, focal changes in histology were observed with some 
tubules being totally degenerative in the neighbourhood of tubules 
of apparently normal appearance. This phenomenon, which has been 
described previously (13,19,20), suggests that there may also be a 
direct effect of the LHRH analogue on the testis (8). However, this 
degenerative pattern has also been described during spontaneous 
atrophy and could be related to withdrawal of androgen from the 
testis (3). It is known that, in addition to their pituitary 
effects, LHRH analogues also have direct effects on the Leydig cells 
of the rat (22), although no morphological changes were observed in 
the Leydig cell in our study. The appearance of multinucleate giant 
cells (Fig. 8.3) has been documented previously by Burek (3). The 
origin of these cells is associated with spermatids. Burek (3) 
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described the formation of multinucleate spermatids as degenerative 
changes. 
Of special interest is the quantitative analysis of changes in 
proliferative activity of testicular cells. During normal 
spermatogenesis, the last duplication of DNA takes place in the 
S-phase of the primary spermatocyte (17). The number of cells in 
the S-phase therefore reflects the proliferative activity of cells 
in the early stages of spermatogenesis. From the decrease of cells 
in the S-phase at day 28 (Fig. 8.5), it can be concluded that the 
drug influences the proliferative activity of spermatogonia and/or 
primary spermatocytes, either directly or indirectly. Whether this 
was a decrease in spermatogonia or in preleptotene spermatocytes, or 
both, remains to be investigated. Because tetraploid cells in the 
testis are mainly pachytene spermatocytes, and only to a lesser 
degree spermatogonia in mitosis (11), Zoladex also seems to 
influence the number of pachytene spermatocytes (Fig. 8.5). 
It can be concluded that Zoladex has a sustained suppressive 
effect on spermatogenesis in adult rats. This new method of 
administration may have practical and pharmacokinetic advantages for 
the purpose of reversible inhibition of spermatogenesis. 
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SURVIVAL OF SPERMATOGONIAL STEM CELLS IN THE RAT AFTER 
SPLIT DOSE IRRADIATION DURING LH-RH ANALOGUE TREATMENT 
M.J.P.G. van Kroonenburgh, W.A.J, van Daal, J.L. Beck, 
H.M. Vemer, R. Rolland and C.J. Herman. 
(Submitted for publication in Journal of the European 
Society for Therapeutic Radiology and Oncology) 
ABSTRACT. A rat model has been created in which a single 
injection of an LH-RH analogue depot preparation (Zoladex, ICI 
118630) produced a temporary interruption of the pituitary-gonadal 
axis. This effect applied during irradiation was investigated as a 
possible mechanism to protect the testis from radiation damage. A 
local testicular irradiation dose of 6.0 Gy was given either as a 
single dose or as a fractionated (2 χ 3.0 Gy) dose at different time 
intervals ranging from 8 to 72 hours. Stem cell survival was 
measured 11 weeks after irradiation by means of the repopulation 
index and the number of haploid cells (spermatids) measured by flow 
cytometry. Serum gonadotrophins and testosterone concentrations were 
measured to evaluate hormonal suppression. No significant 
differences were observed between serum concentrations of FSH, LH 
and testosterone and the duration of the fractionation interval. 
Stem cell survival was higher following fractionated irradiation in 
comparison with the single dose. For the 8 hr interval an increase 
in recovery ratio was found, amounting to 5.0 of the single dose 
value. The fluctuating pattern of the recovery curves indicated 
changes in radiosensitivity of stem cells. The combination of 
hormonal inhibition of spermatogenesis and fractionated irradiation 
led to a decrease in the absolute numbers of stem cells. However, 
the stem cell recovery curves were identical to those seen without 
hormonal inhibition. It was concluded that hormonal pretreatment 
with Zoladex during split dose irradiation had no protective effect 
on stem cell survival. 
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INTRODUCTION 
Although the spermatogonia! stem cells appear to be 
radioresistant cells (3), their state of radioresistance is probably 
not a permanent one (6,10,18,33,34,37). In CBA the mouse 16 hours 
after a single dose of irradiation stem cells showed increased 
radiosensitivity, which reaches a maximum at 20 hours (34). 
Fractionated irradiation could in this way lead to stem cell 
depletion (33,35) by killing stem cells in their radiosensitive 
phase. A survey of the literature on the survival of testicular stem 
cells after fractionated irradiation, however, showed conflicting 
results. Withers et al. (37) and Lu et al. (23) described enhanced 
stem cell survival when the dose was split into two equal fractions, 
whereas Oakberg (21) and Cattanach (2) reported no consistent 
changes. The conflicting data on stem cell survival after split dose 
irradiation may be attributed to the use of different mouse strains 
(27) or to the different methods (23) used in measuring stem cell 
survival. Spermatogonia! stem cell survival after irradiation was 
evaluated in this study by the repopulation index. This method was 
used previously (18,23,32,37) and a good correlation was shown (32) 
between this index and stem cell survival. Sonication-resistant 
spermhead counts may also provide a reasonable measure of stem cell 
survival (25,26). Because the number of haploid cells corresponds to 
the number of spermatids, the number of haploid cells as measured by 
flow cytometry can also be used as a method to measure stem cell 
survival (14). 
In the present study we attempted to protect testicular stem 
cells during irradiation by prior administration of the LH-RH 
analogue depot preparation Zoladex. Temporary interruption of the 
pituitary-gonadal axis by a hormonal drug may prevent stem cells 
from moving into their radiosensitive phase after irradiation. 
Inhibition of follicle stimulating hormone (FSH) and/or luteinizing 
hormone (LH) release or inhibition of their effects on the testicle 
could place the testis in a resting state and could make the stem 
cells more resistant to irradation. This could protect stem cells 
from depletion resulting in preservation of reproductive function. 
Data from the literature in preserving testicular function by 
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hormones during irradiation are very scarce. A recent study (16) 
showed, however, protective effects on the ovaries of rats, when an 
LH-RH analogue was given during irradiation. Concerning the 
protective effect of hormonal inhibition on testicular damage due to 
chemotherapy more data are available (8,11,12,17,22,29). 
MATERIALS AND METHODS 
Zoladex 118630 (ICI PLC, Pharmaceuticals Division, Macclesfield, 
Cheshire, U.K., a depot LH-RH analogue, is a potent pituitary 
gonadotrophin inhibitory agent (7,21) and we therefore used this 
compound to interrupt the pituitary-gonadal axis during irradiation. 
In a previous study (20) a single injection of Zoladex produced a 
marked decrease in serum concentrations of FSH, LH and testosterone 
with a maximum effect 14 days after treatment. Testis weight, serum 
hormone concentrations, and histological, and cytological parameters 
were returned to essentially normal values 52 days after the 
injection. Three-month-old male outbred Wistar rats (Cpb:WU) each 
weighing about 300 g were housed in groups of 4 in well ventilated 
cages at 220C with a day/night rhythm of 12 hours. The animals were 
allowed free access to dry pellet food (RMH-TM HOPE-FARMS, Woerden, 
The Netherlands) and tap water. 108 rats were divided into two 
groups: Group 1 (54 rats), received a single injection of 500 ug 
Zoladex 14 days prior to the start of testicular irradiation 
procedures. Group 2 (54 rats), were irradiated without any 
pretreatment. Testicular irradiation was given either as a single 
dose of 6.0 Gy or split into two doses of 3.0 Gy with time intervals 
of respectively 8, 16, 20, 24, 28, 36, 48 or 72 hours. The rats were 
killed at 10.00h under ether anaesthesia 11 weeks after the 
irradiation procedure. Blood was collected by heart puncture and the 
testes were removed immediately and weighed. After centrifugation 
(1200g, 10 min) serum samples were stored at -200C until analysed. 
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Irradiation conditions 
The rats were anaesthesized with an Alyrane 
(2-chloor-l,1,2-trifluorethyl-difluor methylether) oxygen gas 
mixture and irradiated in prone position with the 18 MV photon beam 
of a Saturne linear accelerator (CGR, BUG, France). The Saturne is 
equipped with a mercury shielded irregular field system device (4) 
which was used to define 4 irradiation portals of 4x5 cm each, so 
that 4 rats could be irradiated on their scrotum simultaneously. To 
achieve a dose homogeneity in the target volume within 10% it was 
necessary to get rid of the build region in the beam. Therefore a 
1.5 cm thick plexiglas plate was positioned just above the rats. The 
dose rate during the experiments was 0.6 Gy/minute. 
Stem cell survival assays 
Spermatogonia! stem cell survival after irradiation was evaluated 
by the repopulation index and by counting the number of haploid 
cells (spermatids) by using flow cytometry. The left testis from 
each sacrificed animal was fixed in Bouin's fluid and embedded in 
paraffin. From each testis three sections, separated from each other 
by a distance of 500 ym, were taken from the midportion of the 
testis and stained with Periodic Acid-Schiff (PAS). The percentage 
of tubules which showed spermatogenic repopulation in histological 
sections, 11 weeks after irradiation, was defined as the the 
repopulation index (23). A tubule was considered to repopulate when 
it contained at least one spermatogonium. The right testis from 
each animal was dissected free from fat and connective tissue. To 
obtain a fluorescent stained single cell suspension, the preparation 
and staining procedure was carried out as previously described (12). 
Haploid cells were measured by flow-cytometric analysis on an Ortho 
System 50-H (Ortho Instruments; Westwood, MA, U.S.A) using the 457 
nm line of the argon ion laser (Spectra Physics, Mountain View, CA, 
U.S.A) at 200 mW power. The stem cell recovery ratio was calculated 
as the ratio of the repopulation index or the absolute number of 
haploid cells in the fractionated and unfractionated irradiated 
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testes. 
Hormone measurements 
Serum concentrations of follicle-stimulating hormone (FSH) and 
luteinizing hormone (LH) were measured by double-antibody solid 
phase radioimmunoassays using the rat gonadotrophin kit reagents 
supplied by NIAMDD, Bethesda, MD, U.S.A. Measurements were expressed 
as vg/l in terms of the NIADDK-rat FSH-RP-1 and LH-RP-1 standards, 
respectively. The minimum detectable concentrations were 10 yg LH/1 
and 50 yg FSH/1. The precision was 5.9% within assays and 6.7% 
between assays for duplicate measurements of FSH in a serum pool 
(mean value 264 yg/l) in 15 consecutive assays. For LH these values 
were, respectively, 3.9% and 9.6% (mean: 59 yg/1) in 15 consecutive 
assays. Testosterone was measured by a dextran-coated charcoal 
(DCC) radioimmunoassay after extraction of serum samples with 
diethyl ether. The antiserum used was raised in a rabbit and 
directed against Testosterone-3-(0-carboxymethyl)-oxime-BSA. The 
sensitivity of the assay was 0.1 nmol/1 and the precision, as 
calculated from a serum pool (mean value: 1.85 nraol/1) after 14 
consecutive measurements), was 3.9% within assays and 5.7% between 
assays. 
Statistical analysis was performed by using the two-sided 
Mann-Whitney U test. Differences were considered to be 
statistically significant when P<0.05. 
RESULTS 
Testicular weights did not show any statistically significant 
differences between two equal doses (3.0 Gy) of irradiation, 
separated by different time intervals ranging from 0 to 72 hours 
(Fig. 9.1). 
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FIG. (9.1) Effects of split dose irradiation (2 χ 3.0 Су) at 
different time intervals with (•) or without (o) Zoladex depot 
pretreatment on mean testicular weight of adult Wistar rats (mean t 
SD; 6 rats/group) 11 weeks after radiation in this and the following 
figures. 
Although the mean testis weight in the rats pretreated with 
Zoladex tended to be lower than in the untreated rats, the 
difference was not significant. The spermatogenic stem cell survival 
as measured by the repopulation index and the number of surviving 
haploid cells (spermatids) 11 weeks after split dose irradiation (2 
χ 3.0 Gy) at various time intervals are presented in Fig. 9.2. 
The two stem cell survival assays showed good agreement and the 
curves showed a fluctuating pattern with a significant (P< 0.05) dip 
in the recovery ratio at 20 hours. A second dip could be observed 20 
hours later. Recovery ratio of stem cells after split dose of 
irradiation (2 χ 3.0 Gy) during interruption of the 
pituitary-gonadal axis by Zoladex is presented in Fig. 9.3. 
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FIG. (9.2) Stem cell survival as measured by the number of haploid 
cells (spermatids, o) and the repopulation index (•) after split dose 
irradiation at different time intervals in adult rats (mean t SD; 6 
rats/group). 
The stem cell recovery curves showed a fluctuating pattern, 
nearly identical to the curves without Zoladex. However, the 
absolute number of haploid cells and repopulation index were 
significant (P< 0.05) different. At the irradiation dose of 6.0 Gy 
(time interval 0 hour) 2.0xl06±l.6xl05 haploid cells were measured 
11 weeks after irradiation, whereas the number of haploid cells was 
4.0xl05±2.4xl0* after hormonal pretreatment, suggesting a 5 fold 
decrease in the number of stem cells. At the irradiation dose of 6.0 
Gy (time interval 0 hour) the repopulation index in the group of 
rats with Zoladex pretreatment significant (P< 0.05) decreased from 
13.3±1.2% to 4.3±0.6V The serum hormone concentrations of FSH, LH 
and testosterone after 11 weeks are shown in Fig. 9.4. No 
significant differences were observed between serum concentrations 
of FSH, LH and testosterone and the duration of the fractionation 
interval. Comparison with previous data (20) from control rats 
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FIG. (9.3) Stem cell survival as measured by the number of haploid 
cells (spermatids, o) and repopulation index (•) after split dose 
irradiation with different time intervals in adult rats (mean ± SD) 
pretreated at 14 days prior to irradiation with a single Zoladex 
depot (500 vg) injection 6 rats/group. 
showed, that the found serum concentrations of FSH, LH and 
testosterone were not statistically different (P< 0.05) from control 
values. 
DISCUSSION 
Our results show enhanced stem cell survival after fractionated 
radiation at time intervals less than 72 hours as measured by two 
different stem cell assays. These results are in accordance with the 
results of Withers et al. (37) and Lu et al. (23). In these studies, 
however, mice were used. The fluctuating pattern of the stem cell 
recovery curves (see Figs. 9.2 and 9.3) may be related to 
fluctuations in radiosensitivity of these cells. This fluctuation in 
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FIG. (9.4) Effects of split dose irradiation (2 χ 3.0 Су) with (о) or 
without (•) Zoladex depot (500 yg) pretreatment in Wistar rats on 
mean serum concentrations of FSH (upper panel), LH (middle panel) 
and testosterone (lower panel), 11 weeks after irradiation. 
radiosensitivity could be attributed to a move of stem cells toward 
a more radiosensitive phase of their cell cycle (6,10,33,34,37). In 
this way, the dip in the curve at 20 hours may reflect the moment at 
which the stem cell enters the very radiosensitive (10) mitotic 
phase. The second dip may then suggest the mitotic phase of the next 
stem cell cycle. The testicular weight showed no significant 
differences between time intervals, indicating that this parameter 
is of little value in estimating stem cell survival. Of special 
interest was the combination of fractionated irradiation with 
hormonal suppression by Zoladex. The split-dose recovery curve 
showed a similar fluctuating pattern. Zoladex had apparently no 
influence on the moment of occurrence of the dip. It seemed that the 
remaining stem cells behaved as if no hormonal suppression had been 
given, suggesting that the stem cells are not under endocrine 
control or the degree of suppression is not great enough to inhibit 
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proliferation. However, during hormonal suppression a distinct 
decrease in the number of stem cells occurred. This decrease needs 
further exploaration. After the single dose of 6.0 Gy (time 
interval 0 hours) the number of stem cells was also decreased, from 
which we conclude that the decrease in the number of stem cells 
probably has little or nothing to do with a move toward a different 
phase in their cell cycle. Although the Zoladex pretreatment 
combined with radiation did reduce the haploid count by a factor 5, 
it is difficult to say if this is a direct five-fold decrease in 
stem cell number. The relationship between spermatid production and 
stem cell number may be linear, however, for the mouse (26), it has 
been demonstrated that although sperm production and stem cell 
survival as measured by RI were highly correlated the relationship 
was not linear. By measuring the number of haploid cells 
(spermatids) as an endpoint for stem cell survival, we disregard the 
fact that all other spermatogenic cells between stem cells and 
spermatids may influence this parameter. In other words, 
intervention in the process of spermatogenesis, could make the 
number of haploid cells inadequate as a stem cell survival assay. 
This is, however, not the case with the repopulation index and since 
the repopulation index also decreased it is very likely that the 
observed decrease in the number of stem cells is real. 
Gonadal dysfunction is an important side effect of radiation 
therapy (13,24). In male patients it can result in permanent 
azoospermia or severe oligospermia (1,2,15,28,31). Even when the 
testes are shielded, internal scatter is still a significant problem 
(36). A treatment which reduces the magnitude of testicular damage 
after irradiation is highly desirable and could result in 
preservation of reproductive function. The agonist LH-RH ethylamide 
has been shown (11,12) to protect the murine testis from damage by 
exposure to cyclophosphamide. The study of Johnson et al. (17), 
however, showed no improvement in post treatment fertility in men 
after chemotherapy when they were treated with an LH-RH analogue. 
The present results lead to the conclusion that the prior 
administration of an LH-RH analogue like Zoladex does not produce 
any substantial improvement in recovery of fertility after 
irradiation. We can not exclude, however, that there may be a 
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protective effect at higher irradiation dose or when the dose is 
multifractionated. Our results indicated that a fractionation 
interval of 8 hours could result in reducing gonadal damage in 
comparison with the 20 hour interval. Of interest in this respect is 
the study of Deringer et al. (9), who observed already in 1954 a 
regain of fertility in mice when time intervals between fractions of 
irradiations of 8 hours were used. Clinical radiation therapy, for 
instance in Hodgkin's disease, frequently employs time intervals of 
about 24 hours, which could destroy stem cells in the most 
radiosensitive phase. Extrapolation of our results to humans or 
even to other species is difficult and further studies are necessary 
to explore this in more detail. 
In the present study we conclude that in Vistar rats changes in 
stem cell radiosensitivity occur most likely in relation to cell 
cycle alterations in the radiation response of the stem cells. Stem 
cell survival was enhanced after split doses of irradiation compared 
with the same dose unfractionated. Hormonal pretreatment with an 
LH-RH analogue depot preparation Zoladex during split dose 
irradiation had no protective effect on stem cell survival. 
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DISCUSSION AND CONCLUSIONS 
Infertility represents one of the main side effects of both 
chemotherapy and irradiation in cancer (42). The threat of reduced 
fertility after radiation exposure has assumed increasing importance 
in view of the increasingly succesful experience in achieving longer 
survival in cancer radiotherapy patients. A treatment which would 
reduce testicular damage and hasten the recovery of reproductive 
function would enhance our ability to bring the treated cancer 
patient back to a normal life (14). 
The aim of this thesis was to test the hypothesis that temporary 
interruption of the pituitary-gonadal axis by hormone like 
substances might protect spermatogonia! stem cells during 
irradiation. This hypothesis was supported by experiments which 
showed, either by counting the spermatogenic repopulation in 
histological sections of the testes (39,58,59) or by the delayed 
return of fertility (61), that spermatogonia! stem cells became more 
radiosensitive after a first dose of irradiation. Surviving stem 
cells are stimulated to divide after irradation (30) and may than be 
at increased risk. Fractionated irradiation could lead in this way 
to less stem cell survival by killing stem cells in their 
radiosensitive phase. Hence the testis may be caught in a 
destructive cycle and stem cell depletion will occur (58,61), which 
eventually results in loss of fertility. Reducing the rate of 
spermatogenesis by hormones could bring the testis into a resting 
state comparable to prepuberty, which may prevent stem cells from 
moving into the radiosensitive phase. This might protect stem cells 
from depletion and hasten the recovery of the reproductive function. 
Matus et al. (43) showed that prepubertal males were indeed less 
vulnerable to gonadal damage due to irradiation or chemotherapy in 
comparison to adults. When discussing testicular irradiation 
effects particular emphasis should be placed on spermatogonia! 
proliferation and on the importance of the stem cell (52,53). The 
irradiation of the stem cell is primarily responsible for the 
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effects of radiation on fertility. This is due to the extreme 
radiosensitivity of spermatogonia. After a moderate dose of 
irradiation most spermatogonia are killed. As a result a 
characteristic maturation depletion can be observed. The testis 
becomes selectively depleted first from spermatogonia and later from 
spermatocytes and spermatids. The only cell which is capable of 
producing new spermatids after irradiation is the relatively 
radiation resistant stem cell. 
Data from the literature in preserving testicular function by 
hormones during irradiation are very scarce. A recent study (33) 
showed, however, protective effects on the ovaries of rats, when an 
LH-RH analogue was given during irradiation. Concerning the 
protective effect of hormonal inhibition on testicular damage due to 
chemotherapy more data are available. The agonist LH-RH ethylamide 
has been shown (14,15) to protect the murine testis from damage by 
exposure to cyclophosphamide. The study of Johnson et al. (35), 
however, showed no improvement in post treatment fertility in men 
after chemotherapy when they were treated with an LH-RH analogue. 
Studies to investigate spermatogonia! proliferation kinetics have 
primarily been performed by microscopical examination of testicular 
tissue (6,7,11,12,29,31,36,37,50), by autoradiography 
(2,19,20,21,22,24,25,26,27,28,49,51,52) and more recently by flow 
cytometry (3,4,16,17,40,45,46,54). In the present study we 
investigated spermatogonia! proliferation by microscopical 
examination and by means of flow cytometric analysis of testis cell 
suspensions. To estimate stem cell survival different assays can be 
used as summarized by Lu et al. (41). The various assays have 
certain advantages as well as disadvantages. For instance counting 
stem cells does not indicate which stem cell will be functional. Lu 
et al. (41) suggested that the conflicting results of stem cell 
survival after split dose irradiation could be attributed to the use 
of different stem cell assays. To rule out this problem in the 
present study we therefore used two different stem cell assays: 
repopulation index and the number of haploid cells. 
With the aid of a computer model of spermatogenesis (Chapter 4) 
we tried to find out to what extent the various stages of the rat 
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spermatogenic cycle could be characterized by their fluorescence 
distribution as measured by flow cytometry. The results from this 
simulation model clearly demonstrated that the processes responsible 
for the changes in fluorescence intensities were primarily a 
reflection of germ cells in the spermatocyte and spermatid stages of 
development and of non-germ cells. Despite the high proliferation 
rate of spermatogonia their numbers contributing to the relative 
proportions of cells within the diploid and tetraploid region were 
very low: 1.25% and 2.0!., respectively. The percentage of the number 
of spermatogonia contributing to the relative proportions of cells 
within the S-phase was calculated by the computer model as 43.0%. 
Thus the only single parameter in DNA measurement which might be 
sensitive enough to reflect early or small changes in the stem cell 
and spermatogonial compartment appeared to be the S-phase. However, 
it remained hard to say if changes in the percentage of S-phase were 
attributable to the number of spermatocytes or to that of 
spermatogonia or both. 
Another feature which was derived from the computer model was the 
finding that one stem cell was able to produce 3185 spermatids. This 
offered the possibility to calculate the total number of stem cells 
per testis in the rat. In a normal non-treated testis about 70 - 90 
million spermatids were found. This resulted in a number of about 
21,000 - 28,000 stem cells per testis. This number has also been 
estimated in the mouse by Meistrich et al. (48). By counting stem 
cells in a whole tubule, these authors estimated a number of about 
20,000 stem cells. So the total number of stem cells is apparantly 
of the same order in these two species. The time required for the 
development of stem cells to the beginning of spermatids was 
calculated by the model to be 40 days. During this development a 
high percentage of cells died, especially during spermatogonial 
proliferation. By changing these degeneration percentages in the 
computer model very little effect in the total percentages of 
diploid, S-phase or tetraploid cells was observed, probably due to 
the very low numbers of spermatogonia in comparison with other 
spermatogenic cells. From the model it also became evident that the 
detection or quantitation of spermatogonial stem cells with flow 
cytometric analysis of testicular cell suspensions is impossible. 
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These calculations were based on flow cytometric analysis using the 
single parameter of total DNA stainability. Differences in chromatin 
structure as well as the size of the nucleus of the various germ 
cells could also be measured and analyzed as separate parameters. 
Using two-parameter flow cytometry (chapter 5) of rat testis cell 
suspensions more subpopulations could be distinguished. This gave 
more detailed information as compared to single parameter DNA flow 
cytometry. In this way eight subpopulations were detected and 
analyzed. This distinction allowed separate analysis of effects on 
germ cells. Using this two-parameter DNA analysis it was also 
possible to distinguish non-germ cells from germ cells. Concerning 
spermatogonia! proliferation and stem cell proliferation this 
distinction gave us no extra information, however, of interest were 
the binucleated cells with typical bean-shaped nuclei and a very 
dense nuclear chromatin structure. These cells have an octaploid DNA 
content. It is not likely that the relatively large sized octaploid 
cells were stem cells, although this is not totally impossible. 
These cells could be compared with the giant stem cells as described 
by Erickson (12). To prove this further research is needed. 
The relationship between the rate of recovery of sperm production 
after irradiation and stem cell survival (47) makes it possible to 
use flow cytometric measurements as a reliable and rapid method for 
an indirect quantitative estimation of stem cell survival by 
counting the number of haploid cells. Haploid cells correspond to 
spermatids and to no other testicular cells. Theoretically the total 
number of tetraploid cells can also be used for this purpose. 
According to the computer model tetraploid cells consist for 98% of 
pachytene spermatocytes. However, this may not be the case after 
irradiation of the testis. The relative proportion contributing to 
the tetraploid region (spermatogonia and pachytene spermatocytes) 
could change by irradiation making this method inadequate for 
quantitative estimation of stem cell survival. 
Using the number of haploid cells as a stem cell assay, a stem 
cell survival curve was obtained (chapter 6). A mean Do value for 
the stem cell in the Wistar rat was calculated as 2.08 Gy. This 
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value was compared with another stem cell assay (repopulation 
index), which has been shown previously (57) to correlate very well 
with stem cell survival. The Do value found with this assay was 2.33 
Gy. These results were different from the data of Clow and Gilette 
(7) and Erickson (12) who found higher Do values for rats (3.8 Gy 
and 3.7 Gy, respectively). Our data in the Wistar rat are in 
agreement with those of Meistrich et al.(48), Ruiter-Bootsma et al. 
(58) and Withers et al. (64) who found Do's of 1.96, 2.42 and 1.80 
Gy, respectively. The low Do value found in the Wistar rat could 
possibly be explained by the differences between the strains. In our 
studies we used Wistar rats, whereas Clow and Gilette (7) and 
Erickson (12) used Spraque-Dawley rats. 
The effects of a single dose of 3.0 Gy X-irradation on the testis 
of the rat showed that minimal numbers of spermatogonia were 
observed within the first two weeks after irradiation. A maturation 
depletion occurred, which resulted in loss of sperm. It was noticed 
that recovery of spermatids started 52 days after the irradiation. 
Theoretically, if all the surviving "As" spermatogonia started 
differentiating immediately, it would require 40 days to produce 
sperm (computer model, chapter 4), so a time delay of more than 12 
days occurred before the initiation of repopulation. According to 
the stem cell renewal model of Huckins (28), there are two types of 
stem cells: one with a short cycle (about 40 hours) and the other, 
probably the true stem cells, with a much longer cell cycle (about 
13 days). Our findings suggested that a single dose of irradiation 
of 3.0 Gy killed the stem cell with the short cycle. The time delay 
of more than 12 days could be explained either by the fact that only 
stem cells with the long cycle (13 days) survived this dose or that 
stem cells first repopulate themselves within 12 days rather than 
starting differentiating immediately. It has been shown, however, by 
Withers et al. (64) that repopulation of stem cells in mice did not 
occur within several weeks after irradiation. If all stem cells 
survived and no enhancement occurred, theoretically spermatogenesis 
would be fully recovered after irradiation in 65 days (Chapter 4). 
Of interest was the number of spermatids at day 65 after this 3.0 Gy 
irradiation dose. This number was 62% of the normal value, 
suggesting that at least 62% of the stem cells escaped the radiation 
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effect. 
As far as the hormonal environment following irradiation is 
concerned, several studies reported an increase of FSH 
(1,9,23,34,63), depending on the used dose. Conflicting results, 
however, have been reported when the dose was about 3.0 Gy. 
(8,23,34,63). Our hormone measurements confirmed the observations of 
Cunningham and Huckins (8) and Verjans and Eik-Nes (63) that at this 
dose the absence of spermatogonia, spermatocytes or spermatids did 
not affect serum hormone concentrations of FSH and LH. 
To interrupt the pituitary-gonadal axis two hormone-like 
substances were tested: The first drug, Danazol has been shown 
(chapter 7) to suppress effectively the pituitary-gonadal axis. This 
was obtained by daily subcutaneous injections of 4 mg Danazol. At 
this dose a marked and rapid drop in serum testosterone was seen to 
very low levels with a slower decrease in serum FSH and LH and 
testis weight. We showed the inhibition of spermatogenesis primarily 
to take place after the preleptotene stage of primary spermatocytes. 
The decrease in the number of cells in the S-phase suggested that 
Danazol inhibits also proliferation of spermatogonia and/or primary 
spermatocytes. 
The second drug, a new depot LH-RH analogue (Zoladex) has also 
been shown (chapter 8) to have a suppressing effect on the 
pituitary-gonadal axis. This depot formulation was given as a single 
subcutaneous injection (500 yg). After injection, the drug slowly 
degrades and the LH-RH analogue is released into the systemic 
circulation, resulting in a marked decrease in serum concentrations 
of FSH, LH and testosterone. The suppression with a maximum effect 
at 14 days after drug injection was reversible. Testis weight, 
serum hormone concentrations of FSH, LH and testosterone, and 
histological and cytological parameters returned to essentially 
normal values 52 days after injection. Zoladex was choosen for 
further experiments since a single injection previous to irradiation 
gives a more or less complete but absolutely reversible suppression 
of testicular function. 
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To obtain stem cell survival curves after irradiation both stem 
cell survival assays (repopulation index and number of haploid 
cells) were applied (chapter 9). Both assays demonstrated enhanced 
stem cell survival when the irradiation dose was split into 
fractions in comparison with the effect of a single dose. The 
observed fluctuations in the stem cell survival curve could be due 
to fluctuations in radiosensitivity of the stem cell possibly 
related to changes in the phase of the stem cell cycle. Studies on 
the effects of single versus fractionated irradiation on testicular 
stem cells have yielded conflicting results. Our results agreed with 
the observations of Withers et al. (64) and Lu et al. (41) that 
after a split dose irradiation no increase in stem cell 
radiosensitivity could be observed. The conflicting results may be 
attributed to the different methods for measuring stem cell survival 
(41) or to strain differences (48). Since the repopulation index for 
assessing stem cell survival was used, the possibility of different 
results due to different techniques was ruled out. Species 
differences could still be responsible for the differences. All 
previous studies were done with mice. 
Much to our surprise testicular suppression with Zoladex and 
split dose irradiation made the stem cell even more vulnerable to 
gonadal irradiation damage. Hormonal suppression of spermatogenesis 
and irradiation led to an increase in stem cell depletion. This was 
also the case with a single dose of 6.0 Gy. From these findings we 
conclude that the relative increase in vulnerability has probably 
nothing to do with moving into a more sensitive phase of the stem 
cell cycle. The stem cells that had escaped destruction by X-rays, 
behaved as if no hormones were given. In other words, the 
fluctuations in radiosensitivity of stem cells appeared to be a 
rigidly regulated process, in which a hormonal drug apparently had 
no influence. This mechanism is very important and needs further 
investigation. We postulated that the surviving stem cells resumed 
their usual pre-irradiation steady-state proliferation pattern. 
It seems that the administration of LH-RH analogues like Zoladex 
prior to irradiation does not give any improvement in the recovery 
of post treatment fertility. Our experiments indicate, however, a 
new therapeutic strategy for protection of fertility during 
115 
CHAPTER 10 
irradiation, not by hormonal suppression, but by using an 8 hour 
fractionation interval for radiotherapy instead of 24 hours as 
mostly performed. There is, as shown in this thesis, a relatively 
high vulnerability of stem cells if irradiated at 24 hours 
intervals. Of special interest for this hypothesis is the study of 
Deringer et al. (10), who described already in 1954 that mice 
regained fertility after being irradiated with 17.6 Gy at a dose 
rate of 0.088 Gy/ 8h day. Ruiter-Bootsma et al. (59) also observed 
an increase in the number of stem cells after an 8 hour 
fractionation interval. Further work is required to confirm this 
hypothesis. 
Extrapolation of our results to man is difficult. Scanty 
information is available concerning the effects of testicular 
irradiation in the human (18,32,60,62). Spermatogenesis in man has 
been found (56) to be much more radiosensitive than in rodents: 
After an irradiation dose of 1.0 Gy, spermatogenesis will be 
disturbed for months. The difference between responses to 
irradiation could be attributed to differences in spermatogonia! 
stem cell renewal between man and rodents (56). In man the isolated 
"As" stem cell has not been described up till now. Two 
morphologically and apparently functionally distinct spermatogonia! 
cells have, however, been described (5,55): "Ad" (dark) and "Ap" 
(pale). The "Ad" cells are rounded cells with a spherical nucleus 
containing darkly-staining flakes of chromatin. The "Ad" cells do 
not proliferate in the normal testis and these cells are considered 
to be reserve stem cells. The "Ap" cells proliferate and 
differentiate regularly and have lightly staining chromatin. It has 
been found, in contrast to the data in rodents, that the numbers of 
"Ad" and "Ap" decreased very slowly during a period of several 
months after irradiation (56). Restoration of fertility is a 
function of stem cell survival and the kinetics of regeneration and 
repopulation. Differences in these kinetics of stem cell renewal 
could lead to interspecies or strain differences in radiation 
response (13,48). In man surviving stem cells after irradiation 
preferentially produce differentiating cells without repopulating 
themselves (56). If stem cells first would differentiate themselves 
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rather than repopulate, this would cause a further, secondary, 
depletion of spermatogonia! reserves. However, if stem cells first 
repopulate themselves rather than differentiate, as is the case in 
rodents, this phenomenon would only result in a delayed recovery 
time (11,50). According to Meistrich et al. (44) the variation of 
this delay is not large. Of interest are the observations of Keulen 
et al. (36,37,38) that in the mouse enhanced stem cell renewal took 
place the first 15 days after cell loss caused by Myleran (an 
alkylating agent). 
CONCLUSIONS 
The results in this thesis lead to the conclusion that the effect 
of gonadal irradiation depends largely on the effects of irradiation 
on the relatively radioresistant stem cell. In rat testis the number 
of these stem cells were calculated to be approximately 24,000. Both 
radiosensitivity and the number of these stem cells were found to be 
comparable to those of mice. Direct quantification of stem cells 
with flow cytometry is not yet possible and quantification of 
spermatogonia! kinetics with flow cytometry is doubtful. Using two 
stem cell-assays (number of haploid cells and the repopulation 
index) it became evident that no increased radiosensitivity occurred 
after split-dose irradiation. Both drugs tested gave a suppression 
of the pituitary-gonadal axis. Temporary interruption of the 
pituitary-gonadal axis by an LH-RH analogue (Zoladex) treatment had 
no protective effect on stem cells of the Wistar rat after split 
dose irradiation with time intervals ranging from 0 till 72 hours. 
Based on these findings it was concluded that the administration of 
an LH-RH analogue (Zoladex) prior to irradation effected no 
substantial improvement in the recovery of post treatment fertility. 
Several reasons can be given for the failure to preserve post 
irradation fertility. The most important reason is probably the fact 
that no increase in radiosensitivity after fractionated irradiation 
occurred and the fact that no change in stem cell behaviour was 
observed after hormonal treatment. We can not exclude that there may 
be a protective effect at higher irradiation doses or when the dose 
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is multifractionated. This certainly needs further investigation. 
Of clinical importance may be the fact that an 8 hour fractionation 
interval could result in less gonadal damage in reference to 
fertility. 
From the foregoing it is evident that there is need for more 
search for a treatment which could reduce the gonadal damage as a 
side effect of irradation. Particular emphasis should be placed on 
the spermatogonia! stem cells, because these stem cells play a 
crucial role after chemotherapy and irradiation in reference to 
fertility effects and little is known about the normal stem cell 
kinetics and the regulation of stem cell renewal. Special attention 
should also be given to the duration of the fractionation interval 
of irradiation. Our study suggests that an 8 hour fractionation 
interval in clinical radiation therapy could result in improvement 
of post treatment fertility. 
References 
1. Bain J and Keene J: Further evidence for inhibin· Change in 
serum luteinizing hormone and follicle-stimulating hormone 
levels after x-irradiation of rat testes. J. Endocr 66, 
278-280, 1975. 
2. Chowdhury AK: Thymidine-Η3 labeling of spermatogonia in rat and 
human seminiferous tubules mounted in toto. Anat. Ree. 169, 
296, 1971. 
3. Clausen OPF, Purvis К and Hansson V: Application of Micro-flow 
fluorometry to studies of meiosis in the male rat. Biol. 
Reprod. 17, 555-560, 1977. 
4. Clausen OPF, Parvinen M and Kirkhus B: Stage-related variations 
m DNA fluorescence distribution during rat spermatogenic cycle 
measured by flow cytometry. Cytometry 6, 421-425, 1982. 
5. Clermont Y : Renewal of spermatogonia in man. Am. J. Anat. 118, 
509-524, 1966. 
6. Clermont Y and Hermo L: Spermatogonia! stem cells in the albino 
rat. Am. J. Anat. 142, 159-176, 1975. 
7. Clow DJ and Guette EL- Survival of type A spermatogonia 
following X-irradiation Rad. Res. 42, 397-404, 1970. 
118 
8. Cunningham GR and Huckins С Serum FSH, LH and Testosterone in 
Co 6 0 Ï irradiated male rats. Radiât. Res 76, 331-338, 1978. 
9. Delie JI, Hendry JM, Morris ID and Shalet SM: Testicular 
endocrine injury in the adult rat after λ-irradiation: Dose and 
time relationships. Proceedings of the seventh international 
congress of radiation research (ed. JJ Broerse et al , Martinus 
Nijhoff Publishers) Amsterdam C2-03, 1983. 
10. Deringer MK, Heston WE and Lorenz E: Effects of long-continued 
total-body Ζ irradiation on mice, guinea pigs and rabbits, IV. 
Actions on the breeding behavior of mice in: R.E. Zirkle (Ed.), 
Biological effects of external X- and Ï-Radiation, McGraw-Hill, 
New York, 149-168, 1954. 
11. Erickson BH: Effect of Co60 Ζ radiation on the stem and 
differentiating spermatogonia of the post puberal rat. Radiât. 
Res. 68, 433-448, 1976. 
12. Erickson BH: Survival and renewal of murine stem spermatogonia 
following Co60 TS radiation. Radiât. Res. 86, 34-51, 1981. 
13. Erickson BH and Hall GG: Comparison of Stem-spermatogonial 
renewal and mitotic activity in the ï-irradiated mouse and rat. 
Mut. Res. 108, 317-335, 1983. 
14. Glode LM, Robinson J and Gould SF: Protection from 
cyclophosphamide-induced testicular damage with an analogue of 
gonadotropropm-releasing hormone Lancet. I, 1132-1134, 1981. 
15. Glode LM, Robinson J, Gould SF, Nett TM and Merril D: 
Protection of spermatogenesis during chemotherapy. Drugs Exptl. 
Clin. Res. 7, 367-378, 1982. 
16. Hacker U, Schumann J and Gohde W: Effects of acute 
i-irradiation on spermatogenesis as revealed by flow cytometry. 
Acta Rad. Oncol. 19, 361-368, 1980. 
17. Hacker U, Schumann J, Gohde W and Muller Κ· Mammalian 
spermatogenesis as a biologic dosimeter for radiation. Acta 
Rad. Oncol. 20, 279-282, 1981. 
18. Hahn EW, Feingold SM and Nisce L: Aspermia and recovery of 
spermatogenesis m cancer patients following incidental gonadal 
irradiation during treatment. Radiology 119, 223-225, 1976. 
19. Hilscher W DNA synthesis; proliferation and regeneration of 
the spermatogonia in the rat. Arch. Anat. Microsc. 56, 75-84, 
1967. 
20. Hilscher W and Hilscher B: Autoradiographische Untersuchungen 
ueber die Kinetic der Spermatogenese der Wistar Ratte unter 
besonderer Berücksichtigung der Spermatocytogenese. Z. 
Zellforsch. 96, 625-640, 1969. 
119 
CHAPTER 10 
21. Hilscher W, Hilscher В and Makoski B: Histologische und 
Autoradiographische Untersuchungen zur "Praespermatogenese" und 
"Spermatogenese" der Ratte. Z. Zellforsch. 86, 327-350, 1968. 
22. Hilscher B, Hilscher W and Maurer W: Autoradiographische 
Untersuchungen ueber den Modus der Prolifaeration und 
Regeneration des Samenepithels der Wistarratte. Z. Zellforsch. 
94, 593-604, 1969. 
23. Hopkinson CRN, Dulisch B, Gauss G, Hilscher W and Hirschlauser 
C: The effect of local testicular irradiation on testicular 
histology and plasma hormone levels in the male rat. Acta 
Endocr. 87, 413-423, 1978. 
24. Huckins C, Kopriwa BM: A technique for the radioautography of 
germ cells in whole mounts of seminiferous tubules. J. 
Histochem. Cytochem. 17, 848-852, 1969. 
25. Huckins C: Cell cycle properties of differentiating 
spermatogonia in adult Spraque-Dawley rats. Cell Tiss. Kinet. 
4, 139-154, 1971. 
26. Huckins C: The spermatogonia! stem cell population in adult 
rats I Their morphology, proliferation and maturation. Anat. 
Ree. 169, 533-558, 1971. 
27. Huckins C: The spermatogonia! stem cell population in adult 
rats II a radioautographic analysis of their cell cycle 
properties. Cell Tiss. Kinet. 4, 313-334, 1971. 
28. Huckins C: The spermatogonia! stem cell population in adult 
rats III Evidence for a long-cycling population. Cell Tiss. 
Kinet. 4, 335-349, 1971. 
29. Huckins C: The morphology and kinetics of spermatogonia! 
degeneration in normal adult rats: An analysis using a 
simplified classification of the germinal epithelium. Anat. 
Ree. 190, 905-926, 1978. 
30. Huckins С and Oakberg EF: Morphological and quantitative 
analysis of spermatogonia in mouse testes using whole mounted 
seminiferous tubules. II The irradiated testes. Anat. Ree. 
192, 529-542, 1978. 
31. Huckins C: Behavior of stem cell spermatogonia in the adult rat 
irradiated testis. Biol. Reprod. 19, 747-760, 1978. 
32. Jackson HL, Hass AC, Sooby D and Marschke CH: The gonadal 
exposure of boys and young men treated with inverted y-fields: 
Its reduction and genetic significance. Radiology 96, 181-186, 
1970. 
33. Jarell J, Younglai EV, Barr R, 0'Connel G, Beibeck L and 
McMahon A: The protection of ovarian follicles from ionizing 
radiation with agonist LHRH ethylamide. (Abstract) Presented at 
120 
the 67 th Annual Meeting of the Endocrine Society, Baltimore, 
Maryland, U.S A. 1985 
34. Jong de FH and Sharpe RM: Gonadotrophins, testosterone and 
spermatogenesis in neonatally irradiated male rats Evidence 
for a role of the Sertoli cell in follicle-stimulating hormone 
feedback J. Endocr. 75, 209-219, 1977. 
35 Johnson DH, Linde R, Hainsworth JD, Vale W, Rivier J, Stein R, 
Flexner J, Van Welch R and Greco A· Effect of a luteinizing 
hormone releasing hormone agonist given during combination 
chemotherapy on posttherapy fertility in male patients with 
lymphoma Preliminary observations. Blood 65, 832-836, 1985. 
36. Keulen van CJG and de Rooij DG- Spermatogonia! stem cell 
renewal in the mouse. II. After cell loss. Cell Tiss. Kinet 6, 
337-345, 1973 
37. Keulen van CJG and de Rooij DG. The recovery from various 
gradiations of cell loss in the mouse seminiferous epithelium 
and its implications for the spermatogonia! stem cell renewal 
theory Cell Tissue Kmet 7, 549-558, 1974. 
38. Keulen van CJG and de Rooij DG: Spermatogenic clones developing 
from repopulating stem cells surviving a high doses of an 
alkylating agent. I First 15 days after injury Cell Tiss. 
Kinet. 8, 543-551, 1975. 
39. Kramer MF, Davids JAG and van der Ven ΤΗΡΑ: Effect of 1 MeV 
fast-neutron irradiation on spermatogonia! proliferation m 
mice. Influence of dose fractionation with different intervals. 
Int. J. Radiât. Biol 25, 253-260, 1974. 
40. Libbus BL, Schuetz AW· Analysis of the progression of meiosis 
in dispersed rat testicular cells by flow cytofluorometry. Cell 
Tiss. Kinet. 11, 377-391, 1978. 
41. Lu CC, Meistrich ML and Thames HD Survival of mouse testicular 
stem cells after У or neutron irradiation. Radiât Res. 81, 
402-415, 1980. 
42. Lushbaugh CC and Casarett GW The effects of gonadal 
irradiation in clinical radiation therapy: A review. Cancer 37, 
1111-1120, 1976. 
43. Matus M, Nicosia SV and Meadows AT Gonadal effects of cancer 
therapy in boys. Cancer 55, 2353-2363, 1985. 
44. Meistrich ML, Hunter NR, Suzuki N, Trostle PK and Withers HR: 
Gradual regeneration of mouse testicular stem cells after 
exposure to ionizing radiation Radiât. Res. 74, 349-362, 1978. 
45. Meistrich ML, Lake S, Steinmetz LL and Gledhill BL· Flow 
cytometry of DNA in mouse sperm and testis nuclei. Mut. Res. 
49, 383-396, 1978. 
121 
CHAPTER 10 
46. Meistrich ML, Lake S, Steinmetz LL and Gledhill BL: Increased 
variability in nuclear DNA content of testis cells and 
spermatozoa from mice with irregular meiotic segregation. Mut. 
Res. 49, 397-405, 1978. 
47. Meistrich ML: Quantitative correlation between testicular stem 
cell survival, sperm production and fertility in the mouse 
after treatment with different cytotoxic agents. J. Androl. 3, 
58-68, 1982. 
48. Meistrich ML, Finch M and Lu CC: Strain differences in the 
response of mouse testicular stem cells to fractionated 
radiation. Radiât. Res. 97, 478-487, 1984. 
49. Monesi V: Autoradiographic study of DNA synthesis and the cell 
cycle in spermatogonia and spermatocytes of mouse testis using 
tritiated thymidine. J. Cell Biol. 14, 1-18, 1962. 
50. Oakberg EF: Initial depletion and subsequent recovery of 
spermatogonia of the mouse after 20 R of Ï rays and 100, 300, 
and 600 R of X-rays. Radiât. Res. 11, 700-719, 1959. 
51. Oakberg EF and Huckins C: Spermatogonia! stem cell renewal in 
the mouse as revealed by H3-thymidine labeling and irradiation. 
J. Endocr. 60, 287-293, 1974. 
52. Oakberg EF: Effects of radiation on the testis. In Handbook of 
Physiology Section 7. Endocrinology Vol. V (ed. Greep RO et al. 
Am. Phys. Soc. Washington), 233-243, 1975. 
53. Oakberg EF: Differential spermatogonia! stem cell survival and 
mutation frequency. Mut. Res. 50, 327-340, 1978. 
54. Pfitzer P, Gilbert P, Rolz G and Vyska K: Flow cytometry of 
human testicular tissue. Cytometry 3, 116-122, 1982. 
55. Rodriquez-Rigau LJ, Zukerman Z, Weiss KD and Steinberger E: 
Hormonal control of spermatogenesis in man:comparisons with the 
rat. In Testicular Development, Structure and function, ed. by 
A. Steinberger and E. Steinberger, Raven Press, New York, 
139-146, 1980. 
56. Rowley MJ, Leach DR, Warner GA and Heller CG: Effect of graded 
doses of ionizing radiation on the human testes. Radiât. Res. 
59, 665-678, 1974. 
57. Ruiter-Bootsma de AL, Kramer MF, de Rooij DG and Davids JAG: 
Response of stem cells in the mouse testes to fission neutrons 
of 1 MeV mean energy of 300 KV X-rays. Methodology, 
dose-response studies, relative biological effectiveness. 
Radiât. Res. 67, 56-68, 1976. 
58. Ruiter-Bootsma de AL, Kramer MF, de Rooij DG and Davids JAG: 
Survival of spermatogonia! stem cells in the mouse after 
split-dose irradiation with fission neutrons of 1-MeV mean 
122 
energy or 300 KV X-rays. Radiât. Res. 71, 579-592, 1977. 
59. Ruiter-Bootsma de AL, Kramer MF, de Rooij DG and Davids JAG: 
Survival of spermatogonia! stem cells in the mouse after 
split-dose irradiation with fission neutrons of 1-MeV mean 
energy. Effect of the fractionation interval. Radiât. Res. 79, 
289-297, 1979. 
60. Sandeman.T.F.θ effects of X-irradiation on male human 
fertility. Brit. J. Radiol. 39, 901-907, 1966. 
61. Sheridan W: The effects of the time interval in fractionated 
X-ray treatment of mouse spermatogonia. Mut. Res. 13, 163-169, 
1971. 
62. Speiser В, Rubin Ρ and Casarett G: Aspermia following lower 
truncal irradiation in Hodgkin's disease. Cancer 32, 692-698, 
1973. 
63. Verjans HL and Eik-Nes KB: Hypothalamic-pituitary-testicular 
system following testicular X-irradiation. Acta Endocr. 83, 
190-200, 1976. 
64. Withers HR, Hunter N, Barkley HT and Reíd BO: Radiation 
survival and regeneration characteristics of spermatogenic stem 
cells of mouse testes. Radiât. Res. 57, 88-103, 1974. 
123 

S U M M A R Y 
The success of radiotherapy and chemotherapy has prolonged the 
survival of cancer patients. However, both radiotherapy and 
chemotherapy have side-effects of which gonadal dysfunction is one. 
This iatrogenic side-effect plays a considerable role in the life of 
patients in the child bearing age. Recent studies in murine have 
shown that the gonads can be protected from the effects of 
chemotherapy by suppression of the pituitary-gonadal axis. We 
hypothesized that the male gonads could also be protected by 
hormonal suppression of spermatogenesis during irradiation. It is 
known that dividing cells are more radiosensitive then non-dividing 
cells Reducing the rate of spermatogenesis by hormones could bring 
the testis into a resting state comparable to prepuberty and in this 
way it could be possible to prevent cell division and at least a 
part of the damage by subsequent irradiation. To test this, a rat 
model was investigated, where hormonal suppression of 
spermatogenesis during irradiation was achieved and stem cell 
survival was measured. Attention was focussed on the stem cell, 
because this cell is primarily responsible for the late effects of 
radiation on fertility. Flow cytometncal and histological 
techniques were used as parameters for measuring stem cell survival. 
Serum concentrations of FSH, LH and testosterone were measured to 
evaluate the hormonal suppression. 
The role of flow cytometry in measuring spermatogonia! and stem 
cell kinetics was evaluated by a computer simulation model. Direct 
quantification of stem- or spermatogonia! cell kinetics appeared to 
be impossible with this technique. Using two-parameter DNA analysis 
(DNA content and the cell size) we were able to distinguish non-germ 
cells from germ cells. Concerning spermatogonia! and stem cell 
proliferation no extra information was obtained. Because there is a 
relation between stem cell survival and the number of spermatids, 
the number of haploid cells (^spermatids) as measured by flow 
cytometry was used as an indirect stem cell assay. This was used in 
combination with the repopulation index, which has been shown in the 
literature to correlate very well with stem cell survival. The 
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radiosensitivity of the stem cells was measured using both stem cell 
assays. A Do value of 2.33 Gy (repopulation index) and 2.08 Gy 
(number of haploid cells) was obtained. An estimation of the number 
of stem cells was calculated by the computer model to be around 
21,000 and 28,000 per testis. Two hormonal substances (Danazol and 
® 
Zoladex ) were used to produce temporary interruption of the 
pituitary-gonadal axis. Both drugs have been shown to suppress 
effectively the pituitary-gonadal axis. The drug Zoladex was 
choosen for further experiments, because the hormonal suppression 
appeared to be almost completely reversible and the method of 
administration has practical advantages. Local testicular 
irradiation was either given as a single dose or split into 
fractions. Conflicting results have been reported in the literature 
about stem cell survival after fractionated irradiation. Our 
results showed that after fractionated irradiation with time 
intervals ranging from 0 till 72 hours stem cell survival was higher 
in comparison with the single irradiation dose. However, stem cell 
survival appeared to be of no constant value, but showed time 
dependent fluctuations with a minimum of survival at 24 hours and a 
maximum of survival at 8 hour irradiation time interval. This 
suggested that an 8 hour fractionation interval could result in less 
gonadal damage in reference to fertility effects in comparison with 
the 24 hour fractionation interval. The combination of hormonal 
suppression of spermatogenesis by Zoladex and fractionated 
irradiation showed no protective effect on stem cells in rats. 
Contrarily, this combination made the stem cell even more vulnerable 
to gonadal irradiation damage and considerable less stem cell 
survival was observed. Based on these findings it was evident that 
the administration of Zoladex prior to irradiation effected no 
substantial improvement in the recovery of post treatment fertility 
in rats. Our study in rats indicated that improvement in fertility 
after irradiation could be achieved by an irradiation fractionation 
interval of 8 hour. Extrapolation of these findings to man is 
difficult, but could be of clinical importance. More research is 
needed to evaluate this finding for clinical use. 
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SAMENVATTING 
Bij de behandeling van oncologische patiënten is grote 
vooruitgang geboekt door zowel radiotherapie als chemotherapie. 
Beide behandelingsmethoden veroorzaken echter ook bijwerkingen, 
waarvan gonadale dysfunctie er een is. De gonadale beschadiging kan 
uitmonden in een lange periode van infertiliteit of zelfs 
steriliteit. Vooral voor jonge patiënten kan dit van groot belang 
zijn. In recente dierstudies is aangetoond, dat door onderbreking 
van de hypofysaire-gonadale as met behulp van hormonen, het 
beschadigend effect van chemotherapie op de gonaden aanmerkelijk 
minder kan zijn. Analoog met deze bevindingen zou het volgens ons 
ook mogelijk moeten zijn door hormonale suppressie van de 
Spermatogenese tijdens bestralingen een bescherming van de gonaden 
te bewerkstelligen. Het is bekend dat delende cellen veel 
stralingsgevoeliger zijn dan cellen in de rustfase. Delende 
stamcellen kunnen dan ook makkelijk door een tweede bestraling 
vernietigd worden. Gefractioneerde bestraling zou op deze manier 
leiden tot een verhoogd stamcel verlies, hetgeen steriliteit tot 
gevolg kan hebben. In dit proefschrift is getracht aan de hand van 
dierexperimenteel onderzoek na te gaan of door middel van hormonale 
suppressie van de Spermatogenese de nadelige effecten van 
radiotherapie op de gonaden kunnen worden gereduceerd. Met name werd 
de aandacht gelegd bij de stamcel, omdat deze een cruciale rol 
speelt met betrekking tot de latere vruchtbaarheid na bestraling. 
Flow cytometrische technieken en histologische quantificatie werden 
gebruikt als parameters voor stamcel overleving. Tevens werden de 
hormoon spiegels van FSH, LH en testosteron bepaald in serum om de 
hormonale suppressie te evalueren. 
Met behulp van een computer simulatie model werd bekeken of het 
mogelijk was om met flow cytometrische technieken de kinetiek van de 
stamcel en spermatogonia te quantificeren. Dit bleek, ook na het 
gebruik van 2-parameter DNA analysis (DNA inhoud en grootte van de 
cel), niet mogelijk te zijn. Wel bleek het mogelijk om cellen 
behorend bij de Spermatogenese en die er niet toe behoren, te 
onderscheiden. Omdat er een relatie is tussen het aantal 
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spermatiden en het aantal stamcellen kan een indirecte maat voor het 
aantal stamcellen verkregen worden, door het aantal haploide cellen 
(=spermatiden) flow-cytometrisch te meten. Deze parameter werd in 
combinatie gebruikt met een histologische stamcel assay (repopulatie 
index). De stamcel stralingsgevoeligheid werd met beide assays 
bepaald. Er werd een Do waarde berekend van 2.33 Gy (repopulatie 
index) en 2.08 Gy (aantal haploide cellen). Het aantal stam cellen 
werd met behulp van het computer model berekend op 21,000 tot 28,000 
3) S) 
per testis. Twee hormonen (Danazol en Zoladex ) werden bij ratten 
S 
getest op hun remmend effect op de Spermatogenese. Zowel Danazol 
® 
als Zoladex gaven een suppressie van de Spermatogenese. De 
experimenten werden voortgezet met Zoladex , omdat dit hormoon een 
reversibele werking en ook practische voordelen had. Bestraling 
werd zowel eenmalig als gefractioneerd gegeven. De literatuur geeft 
verschillende resultaten te zien wat betreft de stamcel overleving 
na gefractioneerde bestralingen. Uit onze resultaten konden we 
concluderen, dat na gefractioneerde bestralingen geen verhoogd 
stamcel verlies optrad. De stralingsgevoeligheid van de stamcel 
vertoonde wel tijdsafhankelijke fluctuaties. Het stamcel verlies was 
het grootst als de tijdsduur tussen de bestraling 24 uur bedroeg en 
het kleinst bij een bestralingsinterval van 8 uur. De combinatie van 
hormonale suppressie (Zoladex ) van de Spermatogenese en gonadale 
bestraling, resulteerde in een aanzienlijk stamcel verlies. De 
resultaten in deze dierstudie suggereren, dat hormonale suppressie 
met Zoladex , uiteindelijk niet zal resulteren in een verbetering 
van de fertiliteit na bestraling. Verbetering met betrekking tot 
latere vruchtbaarheid zou bereikt kunnen worden, wanneer het 
tijdsinterval van bestralingen op 8 uur zou worden gesteld. 
Extrapolatie van deze resultaten naar de mens is moeilijk en 
klinisch onderzoek is nodig om te evalueren of gefractioneerde 
bestraling met een tijdsinterval van 8 uur inderdaad leidt tot een 
verbetering van de fertiliteit. 
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STELLINGEN 
Stellingen behorende bij het proefschrift van 
M.J.P.G. van Kroonenburgh: Hormonal protection 
of spermatogenic stem cells during irradiation 
(A histological, hormonal and flow cytometric 
study in rats). Nijmegen, 1986. 
I 
Indien groepen patiënten met carcinoom vergeleken worden 
volgens de TNM classificatie, dient men rekening te houden 
met het Will-Rogers fenomeen: When the Okies left 
Oklahoma and moved to California, they raised the average 
intelligence level in both states. 
N. Eng. J. Med. 312, 164, 1985. 
II 
Bij Hodgkin patiënten verdient het aanbeveling, zolang er 
nog geen goede methode ter beschikking staat ter 
bescherming van de fertiliteit, het zaad zo spoedig 
mogelijk in te laten vriezen, voordat met therapie 
begonnen wordt. 
III 
Onderzoek naar de invloed van het bestralingsinterval op 
de vruchtbaarheid bij de man dient hoge prioriteit te 
hebben. 
IV 
Het is voor alsnog niet mogelijk om met behulp van de flow 
cytometrie betrouwbare veranderingen in de kinetiek van de 
spermatogonien te meten. 
Bij een stoplicht wordt pas duidelijk dat veel meer mensen 
kleurenblind zijn dan tot nu toe werd aangenomen. 
VI 
Niet betere apparatuur, maar betere samenwerking met 
mensen leidt tot betere resultaten. 
VII 
Tsjernobyl is geen dode waard. 
VIII 
Om voor elke infertiliteits patiente met tuba pathologie 
tot een juiste indicatie stelling te komen, dient 
in-vitro-fertilisatie uitsluitend te worden verricht in 
een centrum waar ook een grote ervaring in tuba chirurgie 
bestaat. 
IX 
Het therapeutisch gebruik van gelabelde monoclonale 
antilichamen tegen maligne aandoeningen behoort nog steeds 
tot het rijk van de magic bullets. 
Het in het openbaar verdedigen van een proefschrift is 
eerder een vorm van vermaak dan dat het de vooruitgang van 
de wetenschap ten goede komt. 



